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iSummary
Diabetes is emerging as a major threat to health, with global economic
and social implications.  Recent research has shown that the morbidity and
mortality associated with diabetes can be reduced by timely and effective
treatment. However, unless people with diabetes have access to this
treatment, the impact of diabetes will continue to rise.   This thesis
therefore explores the current standards of care which people with
diabetes receive. It also looks at factors likely to impact on delivery of
diabetes care.  Studies were conducted at two levels.  In the studies
described in Chapters 2 and 3, general data applicable to all or nearly all
patients with diabetes were collected.  This approach substantially
eliminates selection bias but precludes the ability to examine clinical
outcomes.  In the other studies, detailed in Chapters 4, 5 and 6, specific
aspects of diabetes care pertaining to more select groups of diabetic
subjects were examined.  This approach allows clinical parameters to be
examined in more detail but is more subject to selection bias.  It is hoped
that the combination of these two approaches provides a more balanced
view of the topic under examination.
In Australia, the Medicare Program, a single government controlled
universal health insurance fund, provides access to medical services for all
residents.  Medicare occasions of service data therefore represent the most
comprehensive source of information regarding health service utilisation
ii
in Australia.  The data does not account for people receiving diabetes care
through public hospital based services.  However, a survey of public
hospitals within NSW (n=198), described in Chapter 2, showed that the
number of individuals in this category is relatively small and represents
only 5.2% of the diabetic population.
Using Medicare item codes, and with the permission and assistance of the
Commonwealth Department of Health and Aged Care, data were extracted
on attendance to medical practitioners and utilisation of diabetes related
procedures for people living in New South Wales (NSW) for the
individual years between 1993 to 1997.  All data were stratified by the
presence of diabetes, gender and age group.  Individuals were deemed to
have diabetes if an HbA1c, which can only be ordered for a person with
known diabetes, had been performed over the 5-year period and the
sample size adjusted for the incidence of diabetes.  Once adjusted, the
number of people with diabetes in NSW for the individual years 1993 to
1997 were 143,920, 156,234, 168,216, 177,280 and 185,780.  Comparison
with 1996 census data confirmed a 91.7% capture of the total NSW
population (5,495,900/5,995,545 individuals).
The data were retrieved for NSW as a whole and for individual postcodes.
Postcodes were then classified by population density as either major
urban, urban or rural. On average over the study period, persons with
diabetes accounted for 3.1% of the population but they used 5.5% of
general practitioner services.  As seen in Chapter 2, a large proportion of
iii
people with diabetes were also under the care of specialists and consultant
physicians, up to 51.2% and 41.8% respectively, a 3 to 4 fold increase
when compared with their non-diabetic counterparts.  In regard to
geographical location, once adjusted for age and gender, the odds ratio of
attending a specialist was only slightly higher for people with diabetes
living in areas of high population density when compared to people with
diabetes living in rural areas.  This ratio reached as high as 1.85 in regard
to attendance to consultant physicians (Chapter 3).  The odds ratio for the
non-diabetic population was similar indicating that the difference in
access to consultant physicians was not disease specific.
Analysis of results showed that despite the increase in service utilisation,
large proportions of people with diabetes were not routinely monitored in
regard to diabetes and its complications across the State.  By 1997, HbA1c
was still not performed in over 40% of people with diabetes each year and
only 11.6% of the diabetic population had undergone microalbuminuria
estimation.  Interestingly, the differences in levels of monitoring between
rural and urban areas were surprisingly small.  Monitoring of diabetes and
its complications did improve in all parts of the State over the study
period.  However, the greatest improvement was seen in rural areas,
despite rural patients having fewer attendances to general practitioners
and fewer patients attending specialist care.
In the face of finite resources and the rising prevalence of diabetes, an
increasing number of patients will need to rely on general practitioners to
iv
provide diabetes care regardless of where they live.  A ‘shared care’
approach which encourages and supports general practitioners to manage
patients with diabetes, while giving them access to specialist services for
those patients that require them, is increasingly being advocated as a way
of maximising efficacy while minimising costs.  Yet if health care
professionals leave undone what they think is done by others, shared care
can become neglected care.  Chapter 4 reports a detailed audit of 200
randomly selected shared care patients who were assessed on two or more
occasions.  This study showed that the majority of specialist treatment
recommendations are implemented by general practitioners.  Doctors
formally registered with the Diabetes Shared Care Programme and those
who write longer referral letters were more likely to implement
recommendations than their counterparts.  Moreover, the average HbA1c
and the complication profile of these patients were similar to those found
in various studies around the world.  This suggests that diabetes can be
well managed by a shared care approach that is adequately integrated.
To overcome the problem that data is lacking on those patients that did
not return for specialist review, a further 200 shared care patients who
were lost to follow up from the shared care system were traced.
Information regarding whether treatment recommendations had been
implemented was sought from both the referring doctor and the patient.
Overall, information on 182 of the 200 patients could be obtained.  As
discussed in Chapter 5, comparison of the returned and non returned
patients’ demographic and clinical profiles at time of their initial specialist
vreview showed that general practitioners differentiated between the ‘more
complicated’ patients, choosing to re-refer those with macrovascular
disease, while maintaining the care of ‘less complicated’ patients. Re-
referral for specialist review was also dependent on the patient remaining
under the care of their original doctor.   Encouragingly, general
practitioners seemed to take a more active role in the non-returned group.
They included more details regarding type and duration of diabetes in the
referral letters of patients who were not re-referred for specialist review.
They also implemented more treatment recommendations in the non-
returned group, with the difference in implementation rate for metabolic
recommendations reaching statistical significance.  This study also
showed that movement of patients between doctors raises concern
regarding continuity of care.
The multi-factorial nature of diabetes means that best practice is not easily
accommodated within a single appointment.  Thus continuity of care
becomes an important issue.  To assess the current status, 479 consecutive
patients referred to the Royal Prince Alfred Hospital Diabetes Centre in a
6-month period were recruited and underwent a detailed clinical
assessment.  They were also questioned regarding the number of general
practitioners they attended and the length of time they had been under the
care of the referring doctor.   The results outlined in Chapter 6 showed that
the majority of people with diabetes (87.7%) attended only one general
practitioner and had been under the care of that doctor medium to long
term.  Younger patients, who were relatively healthy apart from the
vi
presence of diabetes, were more likely to attend several general
practitioners or have changed their general practitioner within the last year.
This lack of continuity had little difference on acute outcomes such as
glycaemic and blood pressure control.  Appropriately, continuity of care
increased with increasing age and the increasing prevalence of diabetes
complications, mainly macrovascular disease.
These studies indicate that further efforts are required to improve the
overall standard of diabetes care within Australia.  At present there is a
heavy dependency on specialist services.  As the population ages and the
number of people with diabetes increases, much of this burden will fall on
general practitioners, as is already evident in rural areas.  When provided
with appropriate support and infrastructure, general practitioners are able
to maintain standards of care through referral of patients with more
complex medical problems and by maintaining the degree of continuity
appropriate to the patient’s needs.  However, the collection of relevant
information to monitor future trends in diabetes services provision is
important.  As shown in this thesis, Medicare data represents an easy and
cost effective method with which to do so.
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iSummary
Diabetes is emerging as a major threat to health, with global economic
and social implications.  Recent research has shown that the morbidity and
mortality associated with diabetes can be reduced by timely and effective
treatment. However, unless people with diabetes have access to this
treatment, the impact of diabetes will continue to rise.   This thesis
therefore explores the current standards of care which people with
diabetes receive. It also looks at factors likely to impact on delivery of
diabetes care.  Studies were conducted at two levels.  In the studies
described in Chapters 2 and 3, general data applicable to all or nearly all
patients with diabetes were collected.  This approach substantially
eliminates selection bias but precludes the ability to examine clinical
outcomes.  In the other studies, detailed in Chapters 4, 5 and 6, specific
aspects of diabetes care pertaining to more select groups of diabetic
subjects were examined.  This approach allows clinical parameters to be
examined in more detail but is more subject to selection bias.  It is hoped
that the combination of these two approaches provides a more balanced
view of the topic under examination.
In Australia, the Medicare Program, a single government controlled
universal health insurance fund, provides access to medical services for all
residents.  Medicare occasions of service data therefore represent the most
comprehensive source of information regarding health service utilisation
ii
in Australia.  The data does not account for people receiving diabetes care
through public hospital based services.  However, a survey of public
hospitals within NSW (n=198), described in Chapter 2, showed that the
number of individuals in this category is relatively small and represents
only 5.2% of the diabetic population.
Using Medicare item codes, and with the permission and assistance of the
Commonwealth Department of Health and Aged Care, data were extracted
on attendance to medical practitioners and utilisation of diabetes related
procedures for people living in New South Wales (NSW) for the
individual years between 1993 to 1997.  All data were stratified by the
presence of diabetes, gender and age group.  Individuals were deemed to
have diabetes if an HbA1c, which can only be ordered for a person with
known diabetes, had been performed over the 5-year period and the
sample size adjusted for the incidence of diabetes.  Once adjusted, the
number of people with diabetes in NSW for the individual years 1993 to
1997 were 143,920, 156,234, 168,216, 177,280 and 185,780.  Comparison
with 1996 census data confirmed a 91.7% capture of the total NSW
population (5,495,900/5,995,545 individuals).
The data were retrieved for NSW as a whole and for individual postcodes.
Postcodes were then classified by population density as either major
urban, urban or rural. On average over the study period, persons with
diabetes accounted for 3.1% of the population but they used 5.5% of
general practitioner services.  As seen in Chapter 2, a large proportion of
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people with diabetes were also under the care of specialists and consultant
physicians, up to 51.2% and 41.8% respectively, a 3 to 4 fold increase
when compared with their non-diabetic counterparts.  In regard to
geographical location, once adjusted for age and gender, the odds ratio of
attending a specialist was only slightly higher for people with diabetes
living in areas of high population density when compared to people with
diabetes living in rural areas.  This ratio reached as high as 1.85 in regard
to attendance to consultant physicians (Chapter 3).  The odds ratio for the
non-diabetic population was similar indicating that the difference in
access to consultant physicians was not disease specific.
Analysis of results showed that despite the increase in service utilisation,
large proportions of people with diabetes were not routinely monitored in
regard to diabetes and its complications across the State.  By 1997, HbA1c
was still not performed in over 40% of people with diabetes each year and
only 11.6% of the diabetic population had undergone microalbuminuria
estimation.  Interestingly, the differences in levels of monitoring between
rural and urban areas were surprisingly small.  Monitoring of diabetes and
its complications did improve in all parts of the State over the study
period.  However, the greatest improvement was seen in rural areas,
despite rural patients having fewer attendances to general practitioners
and fewer patients attending specialist care.
In the face of finite resources and the rising prevalence of diabetes, an
increasing number of patients will need to rely on general practitioners to
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provide diabetes care regardless of where they live.  A ‘shared care’
approach which encourages and supports general practitioners to manage
patients with diabetes, while giving them access to specialist services for
those patients that require them, is increasingly being advocated as a way
of maximising efficacy while minimising costs.  Yet if health care
professionals leave undone what they think is done by others, shared care
can become neglected care.  Chapter 4 reports a detailed audit of 200
randomly selected shared care patients who were assessed on two or more
occasions.  This study showed that the majority of specialist treatment
recommendations are implemented by general practitioners.  Doctors
formally registered with the Diabetes Shared Care Programme and those
who write longer referral letters were more likely to implement
recommendations than their counterparts.  Moreover, the average HbA1c
and the complication profile of these patients were similar to those found
in various studies around the world.  This suggests that diabetes can be
well managed by a shared care approach that is adequately integrated.
To overcome the problem that data is lacking on those patients that did
not return for specialist review, a further 200 shared care patients who
were lost to follow up from the shared care system were traced.
Information regarding whether treatment recommendations had been
implemented was sought from both the referring doctor and the patient.
Overall, information on 182 of the 200 patients could be obtained.  As
discussed in Chapter 5, comparison of the returned and non returned
patients’ demographic and clinical profiles at time of their initial specialist
vreview showed that general practitioners differentiated between the ‘more
complicated’ patients, choosing to re-refer those with macrovascular
disease, while maintaining the care of ‘less complicated’ patients. Re-
referral for specialist review was also dependent on the patient remaining
under the care of their original doctor.   Encouragingly, general
practitioners seemed to take a more active role in the non-returned group.
They included more details regarding type and duration of diabetes in the
referral letters of patients who were not re-referred for specialist review.
They also implemented more treatment recommendations in the non-
returned group, with the difference in implementation rate for metabolic
recommendations reaching statistical significance.  This study also
showed that movement of patients between doctors raises concern
regarding continuity of care.
The multi-factorial nature of diabetes means that best practice is not easily
accommodated within a single appointment.  Thus continuity of care
becomes an important issue.  To assess the current status, 479 consecutive
patients referred to the Royal Prince Alfred Hospital Diabetes Centre in a
6-month period were recruited and underwent a detailed clinical
assessment.  They were also questioned regarding the number of general
practitioners they attended and the length of time they had been under the
care of the referring doctor.   The results outlined in Chapter 6 showed that
the majority of people with diabetes (87.7%) attended only one general
practitioner and had been under the care of that doctor medium to long
term.  Younger patients, who were relatively healthy apart from the
vi
presence of diabetes, were more likely to attend several general
practitioners or have changed their general practitioner within the last year.
This lack of continuity had little difference on acute outcomes such as
glycaemic and blood pressure control.  Appropriately, continuity of care
increased with increasing age and the increasing prevalence of diabetes
complications, mainly macrovascular disease.
These studies indicate that further efforts are required to improve the
overall standard of diabetes care within Australia.  At present there is a
heavy dependency on specialist services.  As the population ages and the
number of people with diabetes increases, much of this burden will fall on
general practitioners, as is already evident in rural areas.  When provided
with appropriate support and infrastructure, general practitioners are able
to maintain standards of care through referral of patients with more
complex medical problems and by maintaining the degree of continuity
appropriate to the patient’s needs.  However, the collection of relevant
information to monitor future trends in diabetes services provision is
important.  As shown in this thesis, Medicare data represents an easy and
cost effective method with which to do so.
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1Chapter 1
Literature Review
Introduction
Diabetes is a chronic disease, characterised by hyperglycaemia (high levels
of blood glucose), and is caused by deficient insulin production, resistance
to insulin’s action or a combination of both.  The chronic hyperglycaemia
of diabetes is associated with long term damage, dysfunction or failure of
several organs, especially the eyes, kidneys, nerves, heart and blood
vessels.  Symptoms of hyperglycaemia include polyuria, polydipsia,
weight loss, polyphagia and blurred vision.  Further symptoms of impaired
growth in children and susceptibility to infection are associated with
chronic hyperglycaemia.
In the past diabetes was considered to be a single disease.  However, it is
now clear that diabetes is a heterogeneous metabolic disease caused by
many different mechanisms.  The vast majority of cases fall into two broad
categories, Type 1 and Type 2 diabetes.  These categories are based on
differences in the aetiology, natural history and clinical presentation of the
disorder.
Type 1 diabetes
Type 1 diabetes is ranked as one of the most common childhood diseases
in developed countries (American Diabetes Association, 1993a), although
nearly half of all newly diagnosed cases are in adults (Scott and Brown,
21991).  This form of diabetes most frequently results from a cell mediated
autoimmune destruction of the islet beta cells that are responsible for the
production of insulin (Atkinson and Maclaren, 1994).  Islet cell-related
auto-antibodies against molecules such as glutamic acid decarboxylase and
tyrosine phosphatase-like molecule have been shown to be present in 85%
to 90% of individuals at the clinical onset of Type 1 diabetes (Pozzilli et al,
1998).
The rate of beta cell destruction is variable, being rapid in some
individuals, mainly infants and children, and slower in others, mainly
adults (Zimmet et al, 1994).  This means that some patients, particularly
children, present with ketoacidosis, characterised by extreme
hyperglycaemia and acidosis, while others retain enough residual beta cell
function to prevent ketoacidosis for many years.  At the latter stage of beta
cell destruction there is little or no insulin secretion and insulin therapy is
required for the patient to survive.
The autoimmune destruction of beta cells has multiple genetic
predispositions.  The risk of developing Type 1 diabetes is increased
within families where a member is already effected.  However, more than
80% of cases occur in persons with no family history of Type 1 diabetes
and concordance among identical twins is less than 50%  (Verge et al,
1995; Singh et al, 1998).
3Autoimmune destruction of beta cells is also related to environmental
factors.  For example, children who are breastfed for a shorter time or are
introduced to cow’s milk early may be at increased risk of autoimmune
mediated Type 1 diabetes (Dahl-Jorgensen et al, 1991; Gerstein, 1994).
Rapid growth in infancy has also been linked with an increased risk of
Type 1 Diabetes (Hypponen et al, 1999).   There may also be certain
viruses that act as a catalyst of beta cell destruction (Andreoletti et al,
1998) but this has not been substantiated in large-scale studies.
Type 2 diabetes
Type 2 diabetes accounts for 85% to 90% of all diabetes in developed
countries and virtually all diabetes in developing countries.  It results from
a combination of abnormalities of insulin action and insulin secretion.  In
this type of diabetes, the cells on which insulin mainly acts, muscle, fat
and liver cells are resistant to its action.  This is known as insulin
resistance.  This is usually combined with a relative rather than absolute
insulin deficiency.  Although insulin therapy is often used to treat Type 2
diabetes, persons with this condition are not dependent on insulin therapy
to survive.  Treatment commonly involves management of risk factors,
dietary modification and the use of oral hypoglycaemic agents.
There are probably many different causes of Type 2 diabetes.  According
to the new classification system, once a known cause of diabetes has been
established, such as an insulin receptor mutation or defect in insulin
action, it is no longer considered Type 2 diabetes.  Instead, they are
4grouped as ‘other specific types’ (Alberti and Zimmet, 1998).
Autoimmune destruction of the beta cells was not considered to be a main
aetiological factor.  However, in more recent times it has been found that a
proportion of adults who present with apparent Type 2 diabetes actually
have a slowly evolving autoimmune insulitis, a condition that has been
called latent autoimmune diabetes in adults (LADA) (Tuomi et al, 1993).
Table 1-1. Aetiological classification of disorders of glycaemia
Type 1
            Autoimmune
           Idiopathic
Type 2
Other specific types
           Genetic defects of beta cell function
           Genetic defects of insulin action
           Diseases of the exocrine pancreas
           Endocrinopathies
           Drug or chemical induced
           Infections
          Uncommon forms of immune-mediated diabetes
          Other genetic syndromes sometimes associated with diabetes
Gestational Diabetes
Adapted from Alberti KGMM, Zimmet PZ.  Definition, diagnosis and classification of
diabetes mellitus and its complications.  Part 1: diagnosis and classification of diabetes
mellitus.  Provisional Report of a WHO Consultation.  Diabetic Medicine 1998; 15:539-
53.
5Type 2 diabetes has a strong genetic component with almost 100%
concordance of disease in monozygotic twins (Hitman and McCarthy,
1991).  Although the genes for certain rare forms of diabetes have been
identified, it is likely that multiple genes, in various combinations, acting
on different metabolic functions, are involved in the pathogenesis of the
usual cases of Type 2 diabetes.
The increasing patterns of Type 2 diabetes in developing countries and
migrant populations suggest that factors inherent in Western lifestyles are
also involved (Zimmet et al, 1978; Zimmet, 1992).  The risk of developing
diabetes has been shown to rise with both increasing obesity and physical
inactivity (Perry et al, 1995).  Studies have also linked low birth weight
(Hales and Barker, 1992; Carlsson et al, 1999), maternal weight (Fall et al,
1998) and weight change (Wannamethee and Shaper, 1999) with an
increased risk of developing disease later in life.  Diet is an important
determinant of both obesity and weight gain, therefore it is thought to play
a crucial role in the development of Type 2 diabetes.  High saturated fat
intake has been found to be linked with progression to overt diabetes in
persons with impaired glucose tolerance (Marshall et al, 1994).  In a study
in Da Qing, China, dietary modification was shown to reduce the risk of
developing diabetes by almost a third in persons at risk (Pan et al, 1997).
Type 2 diabetes frequently goes undiagnosed for many years because the
hyperglycaemia develops gradually and at early stages of the disease
process it is often not severe enough for the patient to notice any of the
6classic symptoms of diabetes (Harris et al, 1992). Nevertheless, these
patients are at risk of developing the complications of diabetes.
7The complications of diabetes
Over the course of diabetes a variety of complications can develop, often
resulting in disability or premature death.  These complications can be
broadly classified as microvascular or macrovascular.
Microvascular complications
The microvascular complications of diabetes include retinopathy,
nephropathy and neuropathy (although this complication is likely to have
many other metabolic components in its aetiology). Microvascular
complications appear to result from the interaction of metabolic, genetic
and environmental factors, but most importantly they develop in the
presence of long-standing hyperglycaemia (Pirart, 1978, Brownlee, 1992;
Greene et al 1992; Klein, 1995).  Persons with Type 1 diabetes are
exposed to the disease for a longer duration than their Type 2 counterparts
and consequently exposure to hyperglycaemia and subsequent
microvascular disease is greater for this group (Pirart, 1978; Krolewski et
al, 1985).
Retinopathy is a frequent complication of diabetes and is one of the
leading causes of blindness and visual disability in adults.  The prevalence
of retinopathy increases with duration of Type 1 diabetes; between 50%
and 100% of persons with Type 1 diabetes have evidence of retinopathy
after 20 to 50 years (Klein, 1991).  The prevalence of retinopathy and the
association with duration is not as obvious in the Type 2 population as the
time of onset of disease is not always known.  In this type of diabetes,
8diabetic status is often diagnosed through a routine medical examination
or when they present with symptoms of disease related to diabetes.
Nevertheless, studies have estimated the prevalence of proliferative
retinopathy to be as high as 15% to 20% (Gill, 1986; Klein, 1991).  After
15 years duration, approximately 10% of all persons with diabetes develop
a severe handicap due to retinopathy, glaucoma and cataract while around
2% become blind (Klein, 1991).
Nephropathy is also a major threat to people with diabetes.  The reported
prevalence of nephropathy in persons with Type 1 diabetes is between
35% to 40% (Hanssen et al, 1986; Deckert et al, 1991).  The prevalence in
the Type 2 population is not as well defined, and rates vary between 3%
and 16% for different ethnic populations (WHO Expert Committee on
Diabetes Mellitus, 1980; Dekert et al, 1991).  People with Type 1 diabetes
have a 23 fold increased risk of developing end stage renal disease
(ESRD), which accounts for 55% of overall mortality in this group of
patients (Gill, 1991a).  The risk of ESRD is also increased in persons with
Type 2 diabetes (Leese, 1992), although most die from cardiovascular
disease.
The last microvascular complication, diabetic neuropathy, has been shown
to occur with similar frequency in both Type 1 and Type 2 populations
(Pirart, 1978).  It is one of the most common complications of diabetes
with studies showing that around 7% to 8% of people have diabetic
neuropathy at the time of diagnosis (Pirart, 1978; UK Prospective
9Diabetes Study Group, 1994), rising to over 50% after 25 years duration
(Pirart, 1978).  Diabetic neuropathy can affect the peripheral or autonomic
nervous system.  Peripheral sensory neuropathy is the more common form
of diabetic neuropathy and is a major contributing cause of non-traumatic
lower limb amputation (US Department of Health and Human Services,
1991; Reiber et al, 1992).  It can also cause distressing pain.  Autonomic
neuropathy is less common and may result in bladder and bowel
dysfunction and impotence.  It may also affect the heart (Cowie and
Eberhardt, 1996).
Macrovascular complications
A major cause of morbidity and mortality in persons with diabetes is
atherosclerosis, which manifests itself as coronary heart disease,
cerebrovascular disease or peripheral vascular disease (Pyorala, 1989).
Predisposing risk factors to macrovascular disease in diabetes are the
same as those for the non-diabetic population: smoking, obesity,
hyperlipideamia, hypertension, insulin resistance and platelet
abnormalities, as well as the added risk factors of hyperglycaemia and
hyperinsulinaemia (Reaven, 1988; Hsueh and Anderson, 1992).
In age and sex matches studies it has been shown that the Type 2 diabetes
population has a mortality rate which is twice that of their non-diabetic
counterparts (Panzram, 1987).  Coronary heart disease is the greatest
causes of death in persons with Type 2 diabetes in Caucasian and
industrialised countries.  The estimated mortality rates range between 50%
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to 60% (Kessler, 1971; Panzram, 1987); conferring a 2 to 4 fold increase
in mortality risk compared with the non-diabetic population (Jarrett,
1984).  The mortality rate of coronary heart disease in Type 1 diabetes is
lower and is estimated to be 15% (Gill, 1991a).  While there is a higher
prevalence of obesity, high blood pressure and cholesterol in persons with
diabetes, this does not fully explain this excess of coronary heart disease
(Tuomilehto et al, 1998).
Cerebrovascular disease, which presents as transient ischaemic attack or
stroke, is less prevalent than coronary heart disease. In the United States,
the risk of stroke is 2 to 4 times higher in persons with Type 2 diabetes
when compared with the non-diabetic population (Cowie and Eberhardt,
1996).  The presence of diabetes also doubles the risk of mortality
following stroke (Bell, 1994). Cerebrovascular disease accounts for
approximately 12% to 15% of deaths in persons with Type 2 diabetes and
3% in persons with Type 1 diabetes (Panzram, 1987; Gill, 1991a,b), and is
associated with the risk factors hyperglycaemia, hypertension and
smoking (Oppenheimer et al, 1985; Morrish et al, 1991).
Peripheral vascular disease is more common in persons with diabetes than
health control subjects (Janka et al, 1980).  People with Type 2 diabetes
have been found to have 4 to 8 times the risk of peripheral vascular
disease, which causes intermittent claudication or rest pain (Cowie and
Eberhardt, 1996).  The prevalence of peripheral vascular disease in
persons with Type 2 diabetes is estimated at 12%, and rises with the
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duration of diabetes (WHO Expert Committee on Diabetes Mellitus,
1980).
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The importance of glycaemic control
The complications of diabetes described above result in increasing
disability, reduced life expectancy and enormous health costs for virtually
every society.  However, with advances in diabetes medicine and clinical
practice, there is the distinct prospect of improved prognosis for persons
with diabetes.
Control of blood glucose has always been deemed an essential component
of diabetes management.  However, it wasn’t until the early 1990’s that
the Diabetes Control and Complications Trial (DCCT), which studied the
effect of intensified glycaemic control on 1,411 Type 1 subjects over a
period of 10 years, showed unequivocally that maintenance of near
normoglycaemia was associated with a 40% to 70% reduction in risk of
microvascular complications.  This landmark study concluded that,
notwithstanding the 2 to 3 fold increase in hypoglycaemia, intensive
therapy results in a delay in the onset and a major slowing of the
progression of the microvascular and neurological complications of
diabetes (Diabetes Control and Complications Trial Group, 1993).
The Ohkubo study and the United Kingdom Prospective Diabetes Study
(UKPDS) showed that persons with Type 2 diabetes also benefited from
tight management of glycaemic control (Ohkubo et al, 1995; UK
Prospective Diabetes Study Group, 1998a,b).  This latter study recruited
5,102 patients with newly diagnosed Type 2 diabetes in 23 centres within
the United Kingdom between 1977 and 1991.  Patients were followed for
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an average of 10 years to determine whether intensive use of
pharmacological therapy to lower blood glucose would result in clinical
benefits, that is reduced macrovascular and microvascular complications,
and whether the use of sulphonylureas, metformin or insulin, had specific
therapeutic advantages or disadvantages.  The results of this study
established that microvascular disease can be reduced in persons with
Type 2 diabetes by lowering blood glucose levels.  In the UKPDS, the
overall microvascular complication rate was decreased by 25% (UK
Prospective Diabetes Study Group, 1998a).  While there was no
statistically significant effect of lowering blood glucose on macrovascular
complications, a 16% reduction (P=0.052) in the risk of combined fatal or
non-fatal myocardial infarction and sudden death was observed.
The DCCT and UKPDS are the longest and largest prospective studies
confirming that lowering blood glucose concentrations slows or prevents
the development of diabetic complications.  As such, they have major
implications for health care providers and their patients.
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The importance of treating blood pressure and lipids in diabetes
Despite the health and social implications of microvascular disease,
mortality is often recognised to be a key marker of the impact of a disease.
Mortality rates for patients with diabetes are 2 to 3 times higher than in
people without diabetes (Riley et al, 1995).  While the microvascular
complication, nephropathy, accounts for 55% of deaths in persons with
Type 1 diabetes (Gill, 1991a), cardiovascular disease is the major cause of
death in persons with Type 2 diabetes.  Coronary heart disease alone
confers a 2 to 4 fold increase in mortality risk compared with non-diabetic
individuals (Jarrett, 1984).  Thus the prevention and treatment of
macrovascular complications is of prime importance in the Type 2
population.
Unlike the clear relationship of glycaemia with microvascular disease,
where the reduction in microvascular disease is proportional to the
reduction in hyperglycaemia (UK Prospective Diabetes Study Group,
1998a), a relationship with macrovascular disease and mortality is clouded
by the many risk factors that cause cardiovascular disease.  As previously
discussed, the UKPDS showed that lowering of blood glucose resulted in
a 16% reduction in the risk of combined fatal or non-fatal myocardial
infarction and sudden death but this reduction was not statistically
significant.  While blood glucose has not been clearly identified as a
strong risk factor, diabetes is a strong and established risk factor for
macrovascular morbidity and mortality.  Multiple mechanisms exist for
the increased incidence of macrovascular disease and for increased
15
morbidity and mortality once macrovascular disease occurs (Jacoby and
Nesto, 1992;  Aronson et al, 1997).  High triglyceride levels, low HDL
cholesterol and predominance of small, dense LDL particles increase the
risk of plaque formation.  Higher rates of hypertension are also present
among diabetic individuals.  In addition to increased plaque formation,
diabetes is associated with thrombogenesis due to higher levels of
fibrinogen and reduced fibrinolytic activity (Ceriello, 1993).
In terms of reducing morbidity and mortality for persons with Type 2
diabetes, it is treatment of these risk factors that has potential for greatest
effect. A post hoc subgroup analysis carried out on data from 202 diabetic
patients and 4,242 non-diabetic patients who had participated in the
Scandinavian Simvastatin Survival Study (4S) showed that lowering of
cholesterol in diabetic patients with coronary heart disease reduced total
mortality by 43% and major coronary heart disease event by 47% (Pyorala
et al, 1997).  A comparison of the 7 year incidence of myocardial
infarction, both fatal and non-fatal, among 1,373 non-diabetic subjects
with the incidence among 1,059 diabetic subjects suggested that even
diabetic patients without a history of cardiovascular disease have an
increased risk of a vascular event, equal to that of the non-diabetic
population with known cardiovascular disease (Haffner et al, 1998).
These findings support the rationale for aggressive lipid treatment for all
persons with diabetes.
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Despite advances in therapeutic agents, lowering blood pressure to fully
normotensive levels is often unachievable, even with multiple agents.
However, aggressive treatment of blood pressure, aiming for a diastolic
blood pressure of below 85 mmHg, confers a risk reduction of 51% in
major cardiovascular events (Hansson et al, 1998) as well as reducing the
risk of heart failure by 56% and stroke by 44% (UK Prospective Diabetes
Study Group, 1998c).  A clear benefit of treating isolated systolic
hypertension was found in an analysis of the diabetic subgroup in the
Systolic Hypertension in the Elderly Program (Curb et al, 1996), with a
lowering in major cardiovascular disease event rates by 34%.  Based on
these and similar findings more intensive treatment of dyslipidaemia and
hypertension are now seen as cornerstones of treatment for patients with
diabetes.
Smoking cessation is also seen as particularly important, since smoking
increases both microvascular and macrovascular disease risk.  The use of
aspirin to decrease thrombogenesis has also been promoted and has been
shown to reduce myocardial infarction by 36% (Hansson et al, 1998).  The
use of beta-blockers and ACE inhibitors in diabetes has also been shown
to be useful in the treatment of hypertension in diabetic individuals (UK
Prospective Diabetes Study Group, 1998c,d).  Indeed, beta-blockers and
ACE inhibitors appear to have much greater benefit to diabetic patients
than to those without diabetes (Nesto and Zarich, 1998).  In the Heart
Outcomes Prevention Evaluation Study, treatment with the ACE Inhibitor
Ramapril reduced rates of death, myocardial infarction, stroke, coronary
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revascularization, cardiac arrest, and heart failure as well as the risk of
developing diabetes and complications related to diabetes (The Heart
Outcomes Prevention Evaluation Study Investigators, 2000a).  In the
subgroup analysis of persons with existing diabetes, Ramipril lowered the
risk of these combined outcomes by 25% and overt nephropathy by 24%
(The Heart Outcomes Prevention Evaluation Study Investigators, 2000b).
These effective and affordable therapies can reduce the chronic
complications of diabetes.  Diabetes is often clustered with dyslipidaemia
and hypertension.  Therefore, many patients will require multiple drugs
and considerable efforts from both health care provider and diabetic
patients will be needed to achieve the maximal therapeutic benefit.
However, our efforts to date are obviously not enough.  A recent report
from the EURODIAB IDDM Complications Study found that less than
half (42.2%) of those patients identified with hypertension were on
treatment and only 11.3% were controlled (defined as a blood pressure <=
140/90 mmHg).  Moreover, the majority (81%) of these patients were only
receiving single drug treatment (Collado-Mesa et al, 1999).   Another
study by Colhurn and colleagues (1999) found that only 46% of patients
with hypertension had their blood pressure controlled at below 160/95
mmHg and only 6% of patients who met guidelines for lipid lowering
treatment were taking appropriate medication.
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Treatment guidelines for diabetes
As outlined above, research is producing increasing amounts of important
new evidence for diabetes care.  Over the last decade, numerous sets of
best practice and consensus guidelines for diabetes care have been
developed (European IDDM Policy Group, 1993; Alberti et al, 1994; NSW
Department of Health, 1996; NHMRC, 1997; American Diabetes
Association, 2000;), based on expert interpretation of this evidence as well
as clinical experience.   These guidelines aim to ensure that all people with
diabetes receive optimal standards of care, to promote consistency in
clinical practice and to ultimately improve health outcomes.
Each of the guidelines recognises the importance of achieving
normoglycaemia, or near normoglycaemia, within the parameters of
patient safety.  They recommend that glycosylated haemoglobin levels, the
most useful measure of glycaemic control, are within two standard
deviations of the mean for the non-diabetic range or within one percentage
point of the upper limit of normal.  In order to monitor progress towards
treatment goals and to detect incipient signs of complications, they also
recognise that persons with diabetes must receive regular medical care.
While American, European and Australian groups differ on the frequency
of the components of the physical examination, they all agree on the need
to regularly monitor weight and blood pressure and perform thorough eye
and foot examinations.  They also emphasise the importance of regular
laboratory evaluation, including glycosylated haemoglobin, lipid profile
and microalbuminuria.
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Do guidelines work?
While these guidelines may provide a framework for ‘quality’ diabetes
care, the overall standard of care is unlikely to change unless they are
recognised and broadly implemented.  A recent Australian study reporting
on the impact of nationally developed guidelines on procedural and
surgical management of coronary heart disease on cardiologists and
cardio-thoracic surgeons within NSW found that only half the respondents
were aware of the guidelines (Shah et al, 1999).  It is obvious that
guidelines can not have an impact on clinical practice when only half of
the key audience is aware of their existence.  The potential for their
irrelevance is even greater when the target audience is wider than the
sample used in this study, where 26% of the respondents had been
consulted during the formulation of the guidelines.
Even if guidelines were widely disseminated and promoted, there remains
a lingering doubt about how effective they can be in achieving the desired
effect of improving the quality of health care.  Unfortunately, previous
studies have demonstrated considerable difficulty in bringing clinical
practice in line with the guidelines.  A study that examined the effect of a
nationally endorsed consensus statement recommending decreases in the
use of Caesarean sections found that the majority of obstetricians agreed
with the recommendation and reported changing their behaviour.
However, data on actual practice showed that the rates of Caesarean
section were 15% to 49% higher than that reported, resulting in only a
slight change from the previous upward trend (Lomas et al, 1989).
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In terms of diabetes, Australian guidelines recommend that persons with
diabetes undergo an ophthalmological review every 2 years, yet a study by
McCarty et al (1998) found that 31.8% of people with diabetes had never
visited an ophthalmologist.  A survey of physician practice behaviours
related to diabetes in the United States reported a wide variation in
adherence to recommendations, with a relatively high adherence for eye
exams and blood pressure examination (~ 80%), but poor adherence with
examination of feet and urinary protein (~ 30 to 50%) (Kenny et al, 1993).
The study also highlighted differences in behaviour between doctors.  For
example, older doctors often had lower adherence rates.  Although this
finding is supported by other studies (Marrero et al, 1991; Jacques et al,
1991; Overland, 1996), it must be interpreted with some caution, as the
physicians were not asked about their adherence based on the age and the
duration of diabetes of the patients under their care, important
characteristics that may have differed between doctor age groups.
In many countries, the majority of persons with diabetes are managed at
the community level.  Many general practitioners feel that experts who
don’t understand general practice develop guidelines (Gupta et al, 1997).
Moreover, general practitioners work in a large, ‘contextual framework’
and environmental factors such as patient load and time constraints, are
likely to have a profound effect on their behaviour and adherence to
guidelines (Starfield, 1994; Veale et al, 1999).
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After a decade of experience with evidence-based guidelines, we now
know that guidelines are not enough.  Integrating clinical prevention into
busy practices is a political and logistical process.  Designed to update and
disseminate new information to practitioners, continuing medical
education has been proposed as a potential mechanism for closing the gap
between evidence based practice and those practices actually taking place.
However, a number of studies have demonstrated that continuing medical
education courses and workshops are not enough to ensure clinicians
incorporate clinical guidelines into their practice (el-Kebbi et al, 1997;
Gerstein et al, 1999).  While Gerstein et al (1999) showed in a large survey
of family physicians that attitudes, knowledge and patterns of practice in
regard to diabetes clinical practice guidelines can be improved short term,
the long-term effect of continuing medical eduction was disappointing.  It
is therefore important to develop or identify systems of care that inherently
provide quality diabetes management.  This is especially important given
the projected epidemic of chronic disease such as diabetes.
22
The evolving diabetes epidemic
Diabetes is certain to be one of the most challenging health problems
facing all nations this century.  It has been estimated to affect over 135
million people throughout the world (King et al, 1998).  Without any
proven methods available to prevent diabetes, the burden of this chronic
disease will continue to rise.  Using the best available epidemiological
data, it is projected that as many as 300 million people will be affected by
diabetes by the year 2025  (Table 1-2).  The overall prevalence of diabetes
will increase by 35%, rising from 4.0% to 5.4%, over this same period.
While diabetes has been thought of as a disease of developed countries, the
anticipated increase in prevalence is estimated to be greater in
economically developing than developed countries, with a rise of 48%
versus 27% (King et al, 1998).
Early work by Zimmet and colleagues documented substantial increases in
the prevalence of Type 2 diabetes in areas where economic development
was accompanied by life style changes and Westernisation (Zimmet  et al,
1977; Zimmet et al, 1978).  The progressive aging of the world’s
population, resulting from better control of communicable diseases and
improved nutrition and hygiene, has also played an important role in the
marked increase in non-communicable diseases such as Type 2 diabetes.
Risk factors such as obesity, inappropriate nutrition and physical inactivity
are also unmasking those at risk of this chronic disease.   This transition in
economic status and disease patterns, combined with the rise in diabetes
related risk factors, has catapulted diabetes from a rare disease at the turn
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of the 20th century to its current position as a major contributor to
disability and death.
Table 1-2. Top 10 countries for estimated numbers of adults with
diabetes, 1995 and 2025
Country 1995
(millions)
Country 2025
(millions)
India
China
United States
Russian Federation
Japan
Brazil
Indonesia
Pakistan
Mexico
Ukraine
All other countries
Total
   19.4
   16.0
   13.9
     8.9
     6.3
     4.9
     4.5
     4.3
     3.8
     3.6
    49.7
  135.3
India
China
United States
Pakistan
Indonesia
Russian Federation
Mexico
Brazil
Egypt
Japan
All other countries
Total
   57.2
   37.6
   21.9
   14.5
   12.4
   12.2
   11.7
   11.6
     8.8
     8.5
 103.6
    300
Adapted from King H, Aubert RE, Herman WH.  Global burden of diabetes, 1995-2025:
prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9): 1414-31.
The personal impact of diabetes
There is no denying that the personal impact of diabetes is substantial.
Diabetes reduces both quantity and quality of life.  The life expectancy for
people with diabetes is, even in developed countries, considerably lower
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than for people without diabetes (US Department of Health and Human
Services, 1991).  In the United States, for example, the life expectancy for
people with Type 1 diabetes is reduced by 15 years or more for those
diagnosed with the disease under the age of 30 years (Cowie and
Eberhardt, 1996).  In terms of quality, it has been shown that people with
diabetes experience increased morbidity and have a lower perception of
self-worth (Jacobson, 1996; Jacobson et al 1997).
While overall absenteeism from work due to sickness is not significantly
greater, absenteeism rises sharply once people with diabetes develop long-
term complications.  These complications can lead to permanent
disability.  Olivera et al (1991) showed that this disability, due mainly to
macrovascular disease and retinopathy, can result in an average of 11
years of work production lost per patient. In the United States it has been
estimated that diabetes accounts for one million lost workdays, 47,800
permanently disabled workers and 6.8% of the total mortality (Fox-Ray et al,
1993).
The economic impact of diabetes
The economic impact of diabetes is also substantial.  The International
Diabetes Federation (1994) calculates that persons with diabetes in
developed countries have health costs 2 to 4 times higher than the general
population.  This figure may be exceeded in either direction in developing
countries, depending on the intensity of care available to people with
diabetes and on the size of the countries health care budget.
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While individual figures vary, the cost of diabetes for countries such as
England and the United States in the late 1980s and early 1990s hovered
around the £500 million and $(US) 20.4 billion mark, and represented 5%
of the gross national production (Gerard et al, 1989; Laing and Williams,
1989; American Diabetes Association, 1993b).  While these estimates are
staggering, they probably underestimate the true cost as many of the
complications of diabetes, particularly those related to the cardiovascular
system, are seldom considered in the cost calculations.  In studies where
cardiovascular disease was considered, it accounted for over 70% of the
total cost of diabetes complications (Jacobs et al, 1991; American
Diabetes Association, 1993b), thus its exclusion would have a major
impact on the reliability of any cost estimate.  Using a much wider
approach to costing, Rubin and colleagues (1994) suggested that the total
health care expenditure for people with diabetes in the United States to be
$(US)105 billion or 1 in 7 health dollars spent.
An even more sobering thought is that the cost of diabetes has risen
disproportionately.  In the United States, the cost of diabetes health care
escalated 380% from 1969 to 1980 while the medical health component of
the consumer price index climbed only 134% over this same period (Songer,
1992).  This rise is likely to continue as the population continues to age.
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  Who should look after people with diabetes
The rise in number of people with diabetes and increasing cost of diabetes
care will necessitate the health care sector to examine who should look
after patients with this chronic disease. Even at present, with increasing
cost and scarcity of hospital beds, it is already a difficult task to have
patients admitted to hospital for initiation of diabetic treatment or for re-
stabilisation.  Long-term follow up also poses a problem.  Over the last
few decades hospital clinics have found themselves facing increasing
numbers of patients who are seen by a constantly changing array of
doctors, many of whom are junior and unfamiliar with the nuances of
caring for a person with a chronic disease (Bending and  Keen, 1992).
Specialist care also has its problems.  Despite relatively small numbers of
patients followed at the specialist level, they constitute a large proportion
of the cost.  For example, a health maintenance organisation in America
found that although patients with diabetes accounted for only 1.5% of
their membership, they used 10% of the health budget.  Most of this
difference was attributed to a 4-fold difference in the use of medical
specialists (Glauber and Brown, 1992).  Without major increases in
funding, specialist diabetes services will find it difficult to meet any
growth in demand and either people with diabetes will receive fewer
specialist services, or fewer people will be seen.  
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It therefore appears inevitable that general practitioners will play an
increasingly significant role in diabetes care.  The advantages of generalist
care are essentially the person to person relationship that exists between
patient and doctor and the fact that diabetes has implications on how
patients live.  General practitioners are the best placed of all health
professionals to take an overall view of the person with diabetes health in
its widest sense and to assist in their physical, psychological and social
support.
Many areas of diabetes management, particularly those related to
metabolic and blood pressure control and encouragement of life style
change can be provided at the general practitioner level. Whitford et al
(1995) conducted a review of diabetes care in North Tyneside in the
United Kingdom from 1991 to 1994.  They noted a significant shift in the
proportion of patients attending primary care over this period.  Of more
importance, they found that attending a general practitioner contributed to
a significantly lower glycosylated haemoglobin. A further study by
McGill and colleagues (1993) found that the majority of general
practitioners referring patients to a Diabetes Complications Assessment
Service at a large teaching hospital in Sydney, Australia, were managing
their patients’ hypertension appropriately.
There is also evidence to suggest that many patients prefer to be managed
by their own general practitioner rather than a hospital specialist (Tasker,
1984; Flemming, 1985; Whitford et al, 1995).  A survey by Kamien et al
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(1995) conducted in a metropolitan area of Perth, Australia, found that
more than 90% of patients were highly satisfied with the diabetes care
they received from their general practitioner.  In another Australian study,
Ward and colleagues (1997) assessed quality of life and patient
satisfaction in a group practice in inner Sydney as well as auditing
metabolic and process outcomes.  This study also showed a high level of
patient satisfaction, but at the cost of sub-optimal quality of care and
significant inter-doctor variation.
While there are advantages in assigning management of diabetes to
general practitioners alone, there are also difficulties.   For example, there
are certain patients that general practitioners may be reluctant to manage
exclusively at the community level.  A comparison of two populations of
patients with diabetes demonstrated that the clinical picture of patients
cared for exclusively by their general practitioner differed from that of
those referred to specialist care, with significantly fewer patients requiring
insulin therapy being managed at the general practice level (Overland et
al, 1998).  These findings were in line with results of an earlier survey of
general practitioners which found that, in the majority of cases where
patients were not referred to specialist care, the general practitioner felt
the patient could be easily managed on diet alone or tablets  (Wyndham,
1995).  There also appears to be reluctance on the behalf of general
practitioners to manage patients with complications of diabetes.  When a
group of primary care physicians in the United States were asked what
care they routinely provided to people with diabetes and when they refer
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patients, almost all managed hypertension and obesity, but ~ 70% referred
patients for specialist care if diabetic complications such as neuropathy or
nephropathy were present (National Institute of Diabetes and Digestive
and Kidney Diseases, 1991).
In some instances, patients who receive their diabetes care exclusively at
the community level fare less well in terms of blood glucose control and
long term complications.  In the early 1980s, Hayes and Harries (1984)
reported on a 5 year follow up of 200 patients randomised to diabetes
follow up through either hospital diabetic clinic or general practice.  Their
findings showed that general practitioner care was associated with a
higher mean glycosylated haemoglobin concentration (10.4% versus
9.5%), an increase in hospital admissions due to medical reasons and a
higher risk of death.   Kemple and Hayter (1991) audited records of 223
patients with diabetes in Bristol around the same time and found that a
considerable number had no diabetes review within the previous year.  A
larger audit by Benett et al (1994) showed similar findings.  The latter
study also found that glycosylated haemoglobin level, the most valuable
test in assessing diabetic control, was documented in only 57% of patients.
While measurement of blood pressure was relatively high (81%),
assessment of feet, eyes and lipids were disappointingly low (37%, 48%
and 34% respectively).
A recent study in the United States found similar rates of glycosylated
haemoglobin estimation, with a glycosylated haemoglobin result
30
documented in only 56% of patients cared for by primary care physicians.
Moreover, for those with a glycosylated haemoglobin level measured,
39% had a result greater than 10%, a level clearly indicative of inadequate
metabolic control.  This study also found that 60% of patients had a serum
cholesterol greater than 5.2 mmol/L but were not on lipid lowering agents
(Peters et al, 1996).
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Diabetes care in Australia
In Australia, as in many parts of the world, it is thought that the care of the
majority of patients with Type 2 diabetes is provided solely by their
general practitioner, without the involvement of diabetes specialists. For
patients requiring specialised care, access to specialist services, provided
by either the public hospital system through traditional diabetes clinics or
in private practice, is dependent on referral from the general practitioner.
Despite the importance of information for future health care planning,
there has only been limited work examining the extent to which people
with diabetes use these services and the standards of care they receive.  A
survey of members of Diabetes Australia, the national organisation for
people affected by diabetes, found that only 41% of Sydney residents with
Type 2 diabetes and 70% of a rural sample nominated their general
practitioner as the main provider of diabetes care (Baker, 1990).  As
membership to Diabetes Australia is voluntary these results may be
biased.  By contrast, the results of the 1989-90 National Health Survey
suggested that general practitioners were seen as the main health care
provider for as many as 90% of the diabetic population (Australian Bureau
of Statistics, 1991).  However, this does not distinguish care for diabetes
or other health problems.
In regard to standards of care, a study conducted in inner Sydney found a
significant proportion of patients cared for exclusively by their general
practitioner had sub-optimal metabolic control and had developed the long
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term complications of diabetes (Overland et al, 1998).  However, the
ability to generalise these results was limited due to the relatively small
catchment area from which the patients were selected.
Two larger studies have been conducted in South Australia and Western
Australia.  In the mid 1990s, Beilby and colleagues (1994) presented
findings of a questionnaire sent to 173 randomly selected general
practitioners working in South Australia which was designed to assess
self-reported diabetes management in the areas of detection, diagnosis,
assessment, monitoring and knowledge.   The research found that a
substantial proportion of doctors did not include monitoring of
glycosylated haemoglobin levels in their routine management of their
diabetic patients.  Only half of the general practitioners surveyed
examined lower limb sensation and more than a third (37% for patients
with Type 1 diabetes and 43% for patients with Type 2 diabetes) assessed
tendon reflexes, tests considered important as part of periodic diabetic
assessment.  The second study by Kamien and colleagues (1994) audited
the medical records of general practitioners working in metropolitan areas
of Western Australia and provided a snap shot of diabetes care.  Findings
from this study showed that the most commonly recorded clinical
parameters were diet, body weight, glycosylated haemoglobin and
ophthalmoscopy however the medical records were highly variable.  Other
important parameters, such as foot examination, were rarely recorded.
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While these studies have helped to shed some light on the possible
inadequacies in regard to the level of care provided, they may not be
representative of the diabetic population as a whole.  For example, the
South Australian study relied on provider self report, a methodology likely
to produce results that exceed actual performance.  There is also the issue
of respondant bias with 24% of eligible doctors failing to return the
questionnaire.  Of more concern, only 42% of eligible doctors recruited
patients for the Western Australian study. It is not unreasonable to assume
that participating general practitioners were more comfortable with having
their diabetes practices scrutinised than were the non-participating
doctors.  If this were true, it suggests that doctors in both studies provided
better care than general practitioners as a whole.  In regard to the latter
study, the possible variable quality of medical records and variable
adherence to medical record review protocol may also have resulted in
either an over or underestimation of the true standard of care.  It would
therefore appear that existing research remains lacking.
Further studies to identify more representative data sources, which are
population based or near population based, are required to assist with
ongoing monitoring of diabetes management within the Australian health
care setting.  Obviously the method used to identify people with diabetes
is of critical importance to ensure accurate assessment of resource
utilisation and standards of care.  While it has been suggested that lists
from Diabetes Australia or The National Diabetes Supply Scheme, a
government funded system to subsidise insulin syringes and blood glucose
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strips, may be useful to identify people with diabetes, these lists are biased
towards those requiring insulin therapy.  A national register to include all
persons with Type 2 diabetes would be exorbitantly expensive and
unrealistic.  On the other hand, smaller data sets using information
collected on patients selected from hospital care or one district alone is
unlikely to be representative of the diabetic population as a whole.
In Australia, the Medicare Program, a single government controlled
universal health insurance fund, provides access to medical and hospital
services for all residents.  Under this system, patients are subsidised for
the cost of attendances to medical officers and associated laboratory and
other investigations.  Information regarding occasions of service are
maintained by the body responsible for the administration of the Medicare
Program, the Health Insurance Commission.  Data regarding patient
characteristics such as age, gender and place of residence are also known.
Data relating to services provided for public patients in hospitals is not
included.  There may also be groups such as the Australian Aboriginal
population who may be more likely to be missed by the Medicare system
for reasons such as non-diagnosis or use of traditional medicine.
Nevertheless, the Medicare database is recognised as the most up-to-date
and representative source of information regarding quantity and type of
health service utilisation.  As will be seen in this thesis, the proportion of
diabetic patients treated by the public hospital system is quite small.
Therefore, the use of Medicare data is able to provide valuable
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information regarding the patterns and standards of diabetes care within
Australia, on a near population based scale.
36
Supporting diabetes care – The shared care approach
In a study by Larme and Pugh (1998) primary care physicians in the
United States rated diabetes as significantly harder to treat than diseases
such as hypertension and angina. While they recognised that the
complexity of diabetes treatment contributed to their frustration, many of
the participants also cited lack of support from the health care system as
an important cause. This would imply that diabetes care at the primary
care level needs support.
As the burden of diabetes care is likely to fall progressively on general
practitioners, it is essential to study the interaction between them and
specialists.  Improved health outcomes for a chronic disease such as
diabetes may be heavily dependent on access to specialised services at the
optimal time.  Alternative models of care, aimed at facilitating improved
integration of primary and secondary care to ensure efficient use of
resources may be crucial to improving quality and outcomes of care.
While the United Kingdom has systematised care by providing mini-
clinics, other countries such as Australia have leaned towards systems of
‘shared’ care.  Shared care is a collaborative approach to coordinating
patient care between specialists and primary health care providers.  Its
purpose is to support general practitioners manage the majority of persons
with diabetes at the primary care level, to improve the efficacy of
secondary care and to transfer the coordination of care from the secondary
care level back to the primary care level.  Ideally, shared care combines
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the strengths of both levels of care and contribute to better health
outcomes for the individual and the community while reducing costs.  The
hypothesis that care will be improved as a result of better relationships
between general practitioners and specialists is, most certainly, a
reasonable one.
In terms of maximising the quality of diabetes care within the confines of
available resources, it is important to consider how much benefit shared
care programmes can achieve.  In the early 1990s, Hoskins et al (1993)
conducted a randomised-controlled trial comparing shared care with
conventional care, comprising of specialist clinics or usual general
practitioner care.  The study recruited 206 patients referred by their
general practitioner to the diabetic clinic of a major teaching hospital in
the inner city area of Sydney, Australia.  Patients were followed for 12
months and key end points of metabolic and blood pressure control,
attendance rates and completeness of clinical notes were recorded.  The
results showed that metabolic control and blood pressure improved
equally in all 3 groups. However, the shared care group had better
attendance rates than either general practitioner alone or specialist care.
Shared care was also better in terms of measurement and recording of
random blood glucose, weight and blood pressure and resulted in a more
appropriate balance of care.  However, this study examined only an acute
intervention in a local area over a relatively short period of time and
excluded patients with diabetic complications or other serious medical
conditions, accounting for nearly a quarter of ‘eligible’ patients. The
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shared care arm was also supported by a liaison nurse who encouraged
patients to return to their general practitioner at 3 monthly intervals for
review of their diabetes.  A longer follow up may have lessened the
patients’ enthusiasm for shared care and enabled assessment of whether
long term shared care improves clinical outcomes rather than just the
process of care.
Two British studies also featured regular prompting of patients and/or
doctors.  Hurwitz and colleagues (1993) conducted a randomised
controlled trial in the Islington area of London comparing hospital clinic
care with prompted care, consisting of 6 monthly reminders for patients to
complete blood and urine tests, followed by a clinical review with their
general practitioner.  Five hundred and seventy patients, who had attended
diabetes clinics in the Islington area over the preceding 2 years and
attended 1 of the 38 general practices agreeing to participate in the study,
were identified.  The 209 patients who agreed to participate were followed
for a median of 2 years, after which time their hospital and general
practitioner notes were reviewed for process and outcome data.  At the
end of the study there were no significant differences in glycaemic
control, number of patients admitted to hospital with a diabetes related
condition or number of deaths between the groups.  However,
measurement and recording of albuminuria, plasma glucose
concentrations and glycated haemoglobin estimations were more frequent
and follow up for retinal screening better with prompted care.
39
The second study conducted by the Diabetes Integrated Care Evaluation
Team (1994) used a pragmatic randomised trial.  By design, the 274
patients agreeing to participate in the study were permitted to chose
between conventional diabetes clinic care and integrated care.  Patients
choosing the later alternative were seen by 1 of 3 participating general
practice groups every 3 or 4 months and in the hospital clinic annually.
Patients choosing clinic care continued to be seen by the clinic at 4
monthly intervals. The hospital clinic’s computer based record system
coordinated patient recall for both arms of the trial.  As with the previous
studies, there were no differences in metabolic control between the groups
at the completion of the study but higher frequencies of examinations and
more visits with the doctor were noted for patients choosing integrated
care.
While these studies reported glycaemic control that were at least as good
in general practice as with specialist care, there are a number of problems
in interpreting and generalising the results.  For example, both studies
enrolled self-selected local practices.  The patients were also self-
selecting, were stabilised, had no medical complications and were already
attending specialist services.  Moreover, the follow up of these trials was
only 2 years.  The reported success of shared care may therefore have
been a reflection of the inclusion of enthusiastic doctors and patients.  The
relatively short follow-up period and the trial context may also have
affected it.
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The studies described above were all published before 1994.
Developments in shared care models have continued since this time, with
potential for both enhancement and reduction in the quality of care.  Our
knowledge of the effects of these developments is limited.    Moreover,
randomised controlled trials, which are arguably the gold standard for the
evaluation of therapeutic interventions, are not necessarily the best design
to study approaches to diabetes care.  Health care delivery is often
complex with a large variability in clinical practice.  The potential to
consider this variability or to include ‘blinding’ of either patient or health
care provider within the study design is clearly not available.  Thus there
is a need to conduct new studies that examine the effectiveness of shared
care in ‘real life’.
41
Conclusions
It is evident by the above review that diabetes is emerging as a major
threat to health, with global economic and social implications on an
enormous scale.  However, recent research has shown that the morbidity
and mortality of diabetes can be reduced and has provided us with the
tools to do so.  However, unless people have access to quality care, the
devastating personal and financial impact of diabetes will continue to rise.
It is therefore important to develop accurate systems to monitor current
standards of diabetes care and to identify models that inherently provide
quality care.  These are the major themes of the studies presented in this
thesis.
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Chapter 2
The pattern and standard of diabetes care in
New South Wales
Introduction
It is estimated that 1.5 million Australians will be affected by diabetes by
the year 2010 (McCarty et al, 1996).  Despite this prediction, very little is
known regarding the general pattern and standard of diabetes care in
Australia, information that is vital for future health care planning.  The
most frequently used methods to monitor diabetes care have been provider
self report and review of medical records.  There are potential limitations
in each of these methods.  Provider self report usually exceeds the actual
performance and is prone to respondant bias.  On the other hand, medical
record review usually results in under-estimation.  Another problem is that
a great deal of our current knowledge is based on patients selected from
hospital care or from one district. The use of these selected data is
unlikely to be representative of the diabetic population as a whole.
Similarly, the use of overseas data would not be the optimal method of
studying local health care delivery.
In Australia, the Medicare Program, a single government controlled
universal health insurance fund, provides access to medical and hospital
services for all residents.  Medicare occasions of service data held by the
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Health Insurance Commission therefore represents the most reliable and
comprehensive source of health service utilisation data in Australia.  The
use of such data may provide valuable information while addressing some
of the limitations of other monitoring methods.  The Health Insurance
Commission Act allows release of Medicare data through the
Commonwealth Department of Health and Aged Care provided that such
release does not enable the identification of individual patients or
providers.  To ensure there is no inadvertent disclosure of confidential
information, access to data relating to less than 60 services is restricted.
However, under section 130(3)(a) of the Act, full data may be released if
it is viewed to be ‘necessary in the public interest’.  After liaising with the
Commonwealth Department of Health and Aged Care certified release of
data relating to diabetes care was granted using this section of the Act.
The study described in this Chapter used this information to construct a
profile of diabetes care for people living in NSW over a 5-year period.
44
Method
Identification of individuals with diabetes
Under the Medicare Program, reimbursement for HbA1c is only awarded if
the test is performed in a person with established diabetes.   Therefore,
individuals were deemed to have diabetes if this test had been performed
anytime between 1993 and 1997.  This 5 year capture period was chosen
because some diabetic individuals may not have an HbA1c performed
every year.  To overcome the problem of individuals not developing
diabetes until the latter part of the study period, the data for the first 4
years was adjusted for the incidence of diabetes (Kenny et al, 1995). Once
adjusted, the number of people with diabetes for the individual years 1993
to 1997 were 143,920, 156,234, 168,216, 177,280 and 185,780.
Quantification of medical service usage
Medicare item codes were used to extract data on attendance to medical
practitioners  (general practitioners, specialist, consultant physicians and
ophthalmologists) as well as utilisation of diabetes related procedures
(fluorescein angiography, laser photocoagulation, HbA1c, lipid studies,
HDL cholesterol and microalbuminuria) for people living in NSW for
each of the individual years between 1993 to 1997.
The item codes used for the retrieval are shown in Table 2-1.  Information
on number of individuals and number of services for the selected
Medicare item codes was retrieved and stratified by the presence of
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diabetes, gender and age group (<40 years, 40 to 64 years and > 64 years).
The age group of individuals was based on their age at January 1 of each
year.  Data on any individual without a Medicare service for a particular
12 months was omitted for the remainder of the study period to exclude
people who may have died.  The item codes used to retrieve data on lipids,
HDL cholesterol and microalbuminuria were introduced during 1993.
While information regarding these tests was retrieved for this year they
were not included in this analysis due to possible inaccuracies in the data.
Table 2-1. Medicare item codes used for data retrieval
Service Item code
Attendance to a general practitioner
(surgery consultation)
Attendance to a specialist
Initial attendance to an ophthalmologist
Attendance to a consultant physician
Fluorescein angiogram
Retinal photocoagulation
Lipid studies
HDL cholesterol
Microalbuminuria
HbA1c
3,23,36,44,52,53,54,57
104,105
106
110,116,119
11215,11218
42809
66331,66335,66337,66339,66341
66317
66316
66319
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Estimation of State funded services
In NSW, medical services provided by the public hospital system are
funded by the State health budget and are not captured by Medicare
occasions of service data.  Therefore, some adjustment needs to be made
to include people receiving diabetes care through hospital based services.
Although it is widely suspected that the number of individuals in this
category is relatively small, to calculate the adjustment factor, a short
questionnaire (Appendix 1) was sent to the General Manager and Director
of Pathology Services of all State funded hospitals within NSW (n=198).
The General Manager was asked to provide details regarding whether
their hospital conducted a diabetes clinic, and if so, an estimation of the
number of individual patients seen by the clinic for the previous calender
year. Directors of Pathology of the same hospitals were independently
asked to provide information regarding whether their laboratory
performed HbA1c assays and if so, the number of assays performed for the
previous calendar year.  Further information regarding the proportion of
assays funded by the Federal (Medicare) versus State health system was
also sought.   A stamp-addressed envelope was provided to expedite
return of the questionnaire.  To maximise the response rate, the hospitals
were contacted by telephone if a response had not been received within a
month of the initial mailing.
Statistical methods
Statistical analysis was performed using SAS (SAS Institute Inc, 1991).
The data is presented as the proportion of people with and without
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diabetes using the services.  The data was also analysed in terms of the
average number of services per individual attending the various medical
officers and the average number of tests for patients in whom tests were
performed. The Mantel-Haenszel trend test (Armitage and Berry, 1990)
was used to examine for changes in patterns of care over the study period.
The effect of diabetes on the proportion of patients attending the various
doctors and undergoing surveillance was examined using logistic
regression, adjusting for age and gender and interaction between age,
gender and year.  Results are expressed as average, percentage or adjusted
odds ratio (OR) and 95% confidence interval (95% CI).
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Results
Patterns of attendance to medical practitioners
Comparison with 1996 census data confirmed that 91.7% of the NSW
population (5,495,900 /5,995,545 individuals) use a Medicare service each
year.  On average over the study period, people with diabetes accounted
for 3.1% of the population but used 5.5% of general practitioner services.
As seen in Table 2-2, the mean number of their attendances to general
practitioners over the years 1993 to 1997 remained relatively stable,
ranging from 10.7 to 11.3 visits per year, a 1.8 fold increase when
compared with the non-diabetic population.
A large proportion of people with diabetes also received care by
specialists and consultant physicians. In Australia, specialist disciplines
would include surgeons, some ophthalmologists and obstetricians.  There
was a slight fall in the proportion of people with diabetes seeing a
specialist over the study period (52.3% to 51.2%) while the proportion of
people seeing a physician slightly rose from 37.7% to 38.6%.  While test
for trend showed statistical significance (test for trend: χ2 (df-1) =45.0;
P<0.001 and χ 2 (df-1) = 37.0; P<0.001 respectively), these changes are
unlikely to have any clinical effect.  For the non-diabetic population, the
proportion of people seeing specialists and consultant physicians was
considerably lower, ranging from 25.7% to 26.9% and 11.0% to 12.2 %
respectively.  Attendance to specialists on a per patient basis remained
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stable at 2.9 visits per year, a 1.3 fold increase when compared to the non-
diabetic population.  Attendance to consultant physicians varied between
3.7 and 3.9 visits per patient per year, representing a 1.4 fold increase.
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Table 2-2. Average number of services per person for those people with and without diabetes who attended a general practitioner, specialist
or consultant physician for the years 1993 to1997
Service Provider
1993
Diabetes  No diabetes
1994
Diabetes    No diabetes
1995
Diabetes   No diabetes
1996
Diabetes  No diabetes
1997
Diabetes  No diabetes
General practitioner
Specialist
Physician
    11.3           6.0
    2.9             2.3
    3.9             2.9
    11.2             6.0
    2.9               2.3
    3.8               2.8
    11.2            6.1
    2.9              2.3
    3.7              2.7
   11.1            6.1
    2.9             2.3
    3.8             2.7
   10.7            6.0
    2.9             2.3
    3.8             2.7
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Adherence with clinical and laboratory recommendations
In 1993, only 3.4% of patients with diabetes were billed for an initial
examination by an ophthalmologist.  This fell slightly to 2.3% by 1997
(test for trend: χ2 (df-1) =562.1; P<0.001).  Ophthalmologists frequently bill
using specialist item codes 104 and 105, which are shared with specialists
of other disciplines.  As seen previously, a large proportion of people with
diabetes were billed under these item codes, rising slightly from 51.2% to
52.3% over the study period.  Thus the maximum possible proportion of
patients seen by an ophthalmologist was 54.5%.  The proportion of
patients undergoing fluorescein angiography and laser photocoagulation
remained stable, fluctuating by only 0.2% (2.2% to 2.4%; test for trend: χ2
(df-1) =30.1; P<0.001 and 1.7% to 1.9%; test for trend: χ2 (df-1) =32.8;
P<0.001 respectively).
Table 2-3 lists the frequency of laboratory evaluations performed
compared to the standards of care recommended in Principles of Care and
Guidelines for the Clinical Management of Diabetes Mellitus produced by
the NSW Department of Health (1996).  Changes in adherence to clinical
and laboratory guidelines were more notable in the monitoring of HbA1c
and microalbuminuria.  In 1993, only 48.8% of people with diabetes had a
HbA1c estimation within the 12-month period.  By 1997, this had risen to
56.8%, a rise of 8.0%  (test for trend: χ2 (df-1) =2085.9; P<0.001).  A rise of
similar magnitude was seen in the proportion of patients undergoing a
microalbuminuria estimation (4.7% to 11.6%; test for trend: χ2 (df-1)
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=5488.0; P<0.001).  Improvement in monitoring of lipids was less
marked, with a rise of only 2.6% (49.4% to 52.0%; test for trend: χ2 (df-1)
=295.6; P<0.001).
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Table 2-3. Frequency of laboratory investigations in people with diabetes for the years 1993 to 1997
Test 1993 1994 1995 1996 1997
HbA1c *
          % patients tested
           tests per patient
Lipid studies  † §
      % patients tested
      tests per patient
HDL cholesterol † §
      % patients tested
      tests per patient
Microalbuminuria ‡ §
     % patients tested
      tests per patient
48.9
1.5
51.3
1.5
49.4
1.5
18.3
1.3
4.7
1.1
50.8
1.5
50.1
1.6
19.0
1.3
7.1
1.2
52.8
1.6
51.7
1.6
17.7
1.3
8.5
1.2
56.8
1.5
52.0
1.6
18.8
1.3
11.6
1.2
NSW Health Department (1996) guidelines for the management of diabetes
* 1-4 tests per year
† Every 1 to 2 years if normal, every 3 to 6 months if abnormal or on treatment
‡ Every year
§ Possible inaccuracy as the item codes used to retrieve data on lipids, HDL cholesterol and microalbuminuria were introduced during 1993 therefore information for this
   year is not listed
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The effects of age and gender
The difference in the proportion of diabetic and non-diabetic patients
undergoing clinical and laboratory investigations and attending the
various medical practitioners, adjusted for age and gender, is shown in
Table 2-4.  For patients with diabetes, age and gender had different effects
on attendance to specialist practitioners.  As seen in Table 2-5, the
proportion of patients attending a consultant physician increased with age,
whereas, individuals aged 40 to 64 were significantly less likely to be
under the care of a specialist than their younger counterparts (adjusted
OR: 0.88; 95%CI: 0.84 to 0.92).  Fewer men than women received care at
the specialist level (adjusted OR: 0.51; 95% CI: 0.49 to 0.52).  These
findings are consistent with the obstetric requirements of the younger and
female cohorts.  The effect of gender on attendance to a consultant
physician was less strong.
The effect of age and gender on the frequency of laboratory evaluations in
persons with diabetes is shown in Table 2-6.  While the proportion of
patients with an HbA1c estimation increased with age, there was a bias
towards those aged 40 to 64 in regard to lipid and microalbuminuria
testing.
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Table 2-4. The difference (OR and 95% CI) in the proportion of patients using services over the years 1993 to 1997 for people with diabetes
(people with no diabetes used as reference group), adjusted for age and gender
Service 1993 1994 1995 1996 1997
Attendance to specialist
Initial attendance to
ophthalmologist
Attendance to physician
Fluorescein angiogram
Retinal photocoagulation
Lipid studies *
HDL cholesterol *
Microalbuminuria *
2.97
(2.94 to 3.00)
2.86
(2.78 to 2.95)
4.91
(4.86 to 4.97)
18.28
(17.54 to 19.04)
32.74
(31.0 to 34.6)
2.99
(2.96 to 3.02)
3.07
(2.97 to 3.16)
4.82
(4.77 to 4.87)
16.38
(15.73 to 17.06)
30.23
(28.70 to 31.84)
7.06
(6.99 to 7.13)
6.56
(6.47 to 6.65)
35.04
(33.91 to 36.21)
3.05
(3.02 to 3.08)
2.98
(2.90 to 3.07)
4.75
(4.70 to 4.80)
15.65
(15.05 to 16.28)
27.40
(26.05 to 28.83)
6.87
(6.80 to 6.94)
5.89
(5.82 to 5.97)
53.27
(51.74 to 54.85)
3.05
(3.02 to 3.08)
3.16
(3.06 to 3.25)
4.60
(4.56 to 4.65)
13.85
(13.31 to 14.41)
28.87
(27.50 to 30.30)
6.93
(6.86 to 6.99)
5.17
(5.10 to 5.24)
58.93
(57.35 to 60.55)
3.03
(3.00 to 3.06)
3.13
(3.04 to 3.24)
4.52
(4.48 to 4.57)
16.19
(11.04 to 23.73 )
33.15
(31.60 to 34.77)
6.62
(6.56 to 6.68)
4.92
(4.86 to 4.98)
70.47
(68.78 to 72.19)
* Possible inaccuracy as the item codes used to retrieve data on lipids, HDL cholesterol and microalbuminuria were introduced during 1993 therefore information for this
   year is not listed
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Table 2-5. The effect of age and gender on attendance to specialists and consultant physicians for people with diabetes
Adjusted OR (95% CI)
                                        Specialist                                                       Consultant physician
Age
< 40 years
40-64 years
>64 years
Gender
Female
Male
                                        1.0                                                                  1.0
                                        0.88 (0.84 to 0.92)                                         1.41 (1.34 to 1.48)
                                        1.13 (1.08 to 1.19)                                         1.63 (1.55 to 1.71)
                                        1.0                                                                 1.0
                                        0.51 (0.49 to 0.52)                                        1.03  (1.00 to 1.06)
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Table 2-6. The effect of age and gender on the proportion of people with diabetes with laboratory investigations performed
Adjusted OR (95% CI)
                       HbA1c                              Lipid studies                     HDL cholesterol                    Microalbuminuria
Age
< 40 years
40-64 years
>64 years
Gender
Female
Male
                      1.0                                   1.0                                     1.0                                          1.0
                      1.22 (1.16 to 1.27)           3.77 (3.53 to 4.02)            6.45 (5.79 to 7.19)                 1.77 (1.55 to 2.01)
                      2.29 (2.19 to 2.41)           3.00 (2.80 to 3.21)            6.44 (5.76 to 7.20)                 1.19 (1.04 to 1.36)
                      1.0                                   1.0                                     1.0                                          1.0
                      1.12 (1.09 to 1.15)          1.63 (1.57 to 1.70)             2.15 (2.03 to 2.28)                 1.60 (1.52 to 1.68)
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Adjustment for State funded services
The response rate to the questionnaires sent to the General Managers and
Directors of Pathology of all state-funded hospitals within NSW was
85.4% and 79.8% respectively.  Response rates for both teaching and
major referral hospitals were 100% for both questionnaires.  A total of
10,123 patients attended a hospital diabetes clinic, the majority of whom
(71.6%) attended services based within a teaching or major referral
hospital.  More than 50,000 HbA1c estimations had been performed by
hospital pathology laboratories, 32,198 of which had been funded by the
State health system.
As seen in Table 2-7, assuming no patients attending a diabetes clinic had
been captured by the Medicare occasions of service data (ie. they had not
undergone a Medicare funded HbA1c throughout the 5-year study period),
the total number of individuals with diabetes living in NSW in 1997 rose
to 195,903.  During this year, the combined number of Medicare and State
funded HbA1c estimations were 200,228.
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Table 2-7. Comparison of 1997 findings using Medicare data alone versus data adjusted for State funded services
No. of individuals
with diabetes
% patients attending
a consultant
physician
No. of HbA1c
estimations
% patients
undergoing an
HbA1c *
Medicare data
Adjusted for State
funded services
185,780
195,903
38.6%
41.8%
168,030
200,228
56.8%
68.1%
* Calculated assuming an average of 1.5 tests per patient (Table 2-3)
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Discussion
This study has provided an overview of the current pattern and standard of
diabetes care in NSW.  With over 90% of the population using Medicare
services at least once within a 12 month period, Medicare occasions of
service data held by the Health Insurance Commission represents the most
comprehensive and reliable source of information regarding health
utilisation in Australia.  This data may play a significant role in ongoing
monitoring of patterns and standards of care.  Indeed since the initial release
of data from the Health Insurance Commission, a Best Practice
Implementation Support Project has commenced aimed at promoting best
practice at the primary care level through the use and feedback of similar
Health Insurance Commission data.
The method used to identify people with diabetes is of critical importance to
ensure accurate assessment of resource utilisation and current standards.  A
previous study has shown that over 30% of people with diabetes are
managed on diet alone (Overland et al, 1996), therefore the use of
supplementary secondary data sources, such as Prescription Benefit Scheme
files, would fail to capture a large proportion of the diabetic population.
There are similar problems with using lists from organisations such as
Diabetes Australia and The National Diabetes Supply Scheme as
membership is voluntary and biased towards people requiring insulin
therapy.  A National Registry to include people with Type 2 diabetes would
be exorbitantly expensive and unrealistic.  Using HbA1c to identify diabetic
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individuals addresses these problems. As seen in this study, a large
proportion of people with established diabetes do not have a HbA1c
performed every year, thus limiting its potential to recognise diabetic
individuals if a 12-month capture period is used.
It is unlikely that the use of HbA1c would capture non-diabetic individuals.
As discussed previously, reimbursement for this test is only allowed if it is
performed in a person with known diabetes.  While theoretically some
doctors may use this test to screen persons at risk, this is likely to be
extremely rare.  Moreover, unless a history of established diabetes has been
provided as a clinical indication, the Health Insurance Commission would
not hold details of these tests.
While Medicare data does not account for people receiving care entirely
through hospital based services, over recent decades there has been a trend
towards moving patients traditionally cared for by hospital clinics back to
their general practitioner for ongoing diabetes care.  As seen in this study,
the number of people retained under the traditional hospital model is small
and represents only 5.2% of the diabetic population.  Therefore, at least for
diabetes and for the type of information sought, Medicare occasions of
service data provided a near complete snap shot of the total picture.  The
prevalence of diabetes calculated using Medicare data alone was 3.1%.  This
compares with the 1989-1990 prevalence figure of 2.0% reported by
Welborn and colleagues (1995) using National Health Survey data, which
relied on patient self-report.
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This present study has confirmed the large disparity in service utilisation for
people with diabetes.  It has previously been estimated that 80% to 90% of
people with Type 2 diabetes are managed by their general practitioner alone
(Australian Bureau of Statistics, 1991).  However, our findings show that up
to 41.8% of people with diabetes are under the care of a physician, a 4 fold
increase when compared with the non diabetic population.  Management of
chronic disease does not always fit into general practice where the patient
volume is high and the time for consultations is limited. There will also be
patients who, due to the severity of their disease, need specialist care.  This
is particularly so in diabetes where there is a high prevalence of vascular
disease and other complications.  However, specialist care places a higher
burden on the health care dollar.  A health maintenance organisation in
America found that although patients with diabetes accounted for only 1.5%
of their membership, they used 10% of the health budget (Glauber and
Brown, 1992). Much of this difference was attributed to a 4-fold difference
in the use of specialist services.
These data suggest that practice of diabetes care does not match what is
recommended.  In the past decade, organisations such as the Royal
Australian College of General Practice and the NSW Health Department
have tried to improve standards of care by formally adopting consensus
guidelines for the management of diabetes.  While these guidelines have
been broadly publicised, the overall adherence rate is relatively unchanged.
This has been clearly illustrated by this study.  In early 1996 the Principles
of Care and Guidelines for the Clinical Management of Diabetes Mellitus
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(NSW Department of Health, 1996) were released recommending HbA1c,
the most useful objective measure of the success or failure of treatment of a
diabetic patient, be measured between 2 and 4 times a year depending on the
patient’s treatment mode.  While the proportion of patients undergoing this
test rose throughout the study period, the rise after the guidelines were
widely disseminated was disappointingly small at 4.0%.  By 1997, HbA1c
was still not performed in over 40% of people with diabetes on a yearly
basis.
The guidelines also suggest that microalbuminuria, one of the most useful
screening tools to determine the renal and macrovascular status of patients
with Type 2 diabetes, be assessed  annually.  The poor recognition of the
importance of microalbuminuria is of concern.  The UKPDS has clearly
shown the benefit of treatment of even mild hypertension in terms of
reducing morbidity and mortality (UK Prospective Diabetes Study Group,
1998c), regardless of microalbuminuria status.  However, the argument for
tight blood pressure control is even stronger in the presence of
microalbuminuria. Without information regarding patients’
microalbuminuria status the commencement of timely treatment of
macrovascular risk factors may be delayed with obvious long term effects in
regards to early morbidity.
Effective and affordable lipid agents are now readily available and can
reduce major coronary heart disease events by up to 47% (Pyorala et al,
1997).  Accordingly, the NSW guidelines recommend monitoring of lipids
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every 1 to 2 years if normal, or every 3 to 6 months once the patient is
identified as having a lipid abnormality (NSW Department of Health, 1996).
Despite this recommendation, and a lowering of the lipid drug-prescribing
threshold in the middle of the 1990s, the frequency of lipid monitoring
remained inadequate over the 5-year study period.
In regard to diabetic eye disease, the guidelines recommend a
comprehensive ophthalmological examination be carried out at diagnosis
and then every 1 to 2 years for patients whose diabetes onset was at age 30
years or more.  For those diagnosed at age 30 years or less, the
recommendations suggest review within 5 years of diagnosis and then every
1 to 2 years (NSW Department of Health, 1996).  The findings from this
study suggest actual behaviour falls short of this recommendation.  Even if
the assumption is made that all specialist services were provided by an
ophthalmologist, each year nearly half the diabetic population is not
screened for diabetic retinopathy.  This may underestimate the proportion of
diabetic individuals screened for eye disease as attendance to optometrists
was not assessed in this study.  However, our finding is supported by earlier
work by Kamien et al (1994) that found annual eye examination had been
performed in only 50.1% of diabetic patients attending general practitioners
in metropolitan areas of Western Australia.
The findings presented in this Chapter relate to people with diabetes living
in NSW alone. Whether they can be applied to the rest of Australia is
unknown. It is not unreasonable to assume that diabetes practice varies
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between States, thus a large proportion of Australians diabetes may be
receiving a different standard of care than that found by this study.  It is also
possible that various groups within NSW, such as the Aboriginal population
or people living in remote areas, experience even less adequate care due to
issues of access.
While the limitations regarding the use of Medicare occasions of service
data have been described above, it remains one of the most reliable sources
of data from a nationally representative sample.  It therefore provides unique
information on health service utilisation and standards of care that can be
used by policy makers, economists and service providers.  If minor
modifications are made to Medicare item code numbers, considerable
epidemiological and public health data can be collected for a wide range of
diseases at virtually no cost.  The use of existing data has already served to
highlight the heavy burden imposed by a chronic disease such as diabetes.
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Chapter 3
The impact of geographic isolation on the use of
Medicare services related to diabetes
Introduction
In Australia there is a significant maldistribution of medical practitioners
with many rural areas being under-serviced.   In the mid-1990s, 32% of the
Australian population lived in rural areas yet they were cared for by only
23% of the general practice workforce (Commonwealth Department of
Health and Family Services, 1996). The inequity is even greater in terms of
specialist services.  Of concern in this regard is the issue of access to
appropriate health care for individuals with diabetes.  Current research
shows that the devastating complications of diabetes can be avoided by
timely and effective treatment (Diabetes Control and Complications Trial
Research Group, 1993; Ohkubo et al; 1995; UK Prospective Diabetes Study
Group, 1998a,b).  Accordingly, the NSW Health Department (1996) has
issued management guidelines that define basic medical care for people with
this chronic disease.  These guidelines emphasise preventive practices, close
monitoring and routine visits to medical practitioners.  The implication is if
medical services are limited, this high-risk population may experience
inadequate levels of care.  This may, in turn, have a long-term affect on
health and economic outcomes.
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Information regarding the use of health and medical services for persons
with diabetes living in Australia is relatively scarce. Over 90% of the
Australian population see a general practitioner each year.  Thus Medicare
occasions of service data held by the Health Insurance Commission
represents the most reliable and comprehensive source of health service
utilisation data in Australia.  The study described in the previous Chapter
used this data to construct a general profile of diabetes care for people living
in NSW.  In this Chapter, the data has been used to describe the impact of
geographic location on the use of diabetes health care services.
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Methods
Identification of individuals with diabetes
The sample in this study was drawn from all persons living in NSW with a
Medicare service between 1993 and 1997. Under the Medicare Program,
reimbursement for HbA1c is only awarded if the test is performed in a
person with established diabetes.   Individuals were deemed to have diabetes
if this test had been performed anytime during the study period and the
sample size adjusted for the incidence of diabetes as described in Chapter 2.
Quantification of medical service usage
Medicare item codes were used to extract data on attendance to medical
practitioners  (general practitioners, specialist, consultant physicians and
ophthalmologists) as well as utilisation of diabetes related laboratory
evaluations (HbA1c, lipid studies, HDL cholesterol and microalbuminuria)
for the individuals identified to have diabetes for each of the individual
years between 1993 to 1997.
Information on number of individuals and number of services for the
selected Medicare item codes was retrieved by NSW postcode and stratified
by the presence of diabetes, gender and age group (<40 years, 40 to 64 years
and > 64 years). The age group of individuals was based on their age at
January 1 of each year.  Data on any individual without a Medicare service
for a particular 12 months was omitted to exclude people who may have
died.  The item codes used to retrieve data on lipids, HDL cholesterol and
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microalbuminuria were only introduced during 1993.  While information
regarding these tests was retrieved for this year they were not included in
this analysis due to possible inaccuracies in the data.
Determination of geographic location
Using the population distribution based on the Australian Bureau of
Statistics 1996 Census and the regional classifications outlined by The
Department of Health Services and Health, each postcode was classified by
geographic location.  The locations were major urban centre (population of
100,000 or more), urban centre (population between 1,000 and 99,999),
rural locality (population up to 999).
Statistical methods
Statistical analysis was performed using SAS (SAS Institute Inc, 1991).
The data is presented as the average number of services per individual
attending the various medical officers and the average number of tests for
patients in whom tests were performed, stratified by geographic location.
The data was also analysed in terms of the proportion of people living in
major urban, urban and rural localities using these services. The effect of
location on the proportion of patients attending the various doctors and
undergoing surveillance was examined using logistic regression, adjusting
for age and gender. Results are expressed as average, percentage or adjusted
odds ratio (OR) and 95% confidence interval (95% CI).
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Results
Slightly more than half (50.3%) of the diabetic population identified were
male.  On average over the study period, 139,594 (70.8%) persons with
diabetes lived in major urban, 48,544 (24.6%) in urban and 9,140 (4.6%) in
rural areas of NSW.  This represented a prevalence of diabetes across the 5-
year study period of 3.7%, 3.5% and 3.2% for the major urban, urban and
rural populations respectively.
Attendance to medical practitioners for patients with diabetes
The mean number of attendances to general practitioners remained
relatively stable in all localities, averaging 10.9 visits a year for patients
living in major urban areas, 8.6 visits a year for patients in urban areas and
8.0 visits a year for patients residing in rural areas.  This represented a 1.3
fold greater use of services between major urban and urban areas and a 1.4
fold greater use between major urban and rural areas.
A large proportion of diabetic individuals also received care at the
specialists level with up to 51.3% of patients living in major urban areas,
50.9% of patients in urban areas and 46.8% of patients in rural localities
seeing a specialist each year (Table 3-1).  As seen in Table 3-2, once
adjusted for age and gender, the OR of attending a specialist was slightly
higher for patients living in areas of high population density. The overall
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number of attendances to specialists was also higher for these patients,
averaging 2.9 visits per patient per year compared to 2.6 and 2.5 visits per
patient per year for the urban and rural groups, a 1.1 to 1.2 fold increase.
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Table 3-1. The proportion of patients with diabetes living in major
urban, urban and rural localities attending a specialist,
consultant physician and ophthalmologist during the years
1993 to 1997
Service Region 1993 1994 1995 1996 1997
Attendance to specialist Major urban % patients 46.6 48.0 49.2 50.5 51.3
visits per patient 2.9 2.9 2.9 2.9 2.9
Urban % patients 44.3 46.6 48.6 49.9 50.9
visits per patient 2.6 2.6 2.6 2.7 2.6
Rural % patients 41.0 43.5 47.2 46.4 46.8
visits per patient 2.5 2.5 2.5 2.4 2.5
Attendance to physician Major urban % patients 34.4 36.6 38.1 40.2 41.8
visits per patient 3.8 3.7 3.7 3.8 3.9
Urban % patients 22.3 23.0 26.1 27.4 28.8
visits per patient 3.5 3.1 3.1 3.5 3.2
Rural % patients 21.6 26.0 28.5 26.7 29.4
visits per patient 3.5 2.8 3.1 3.3 3.8
Initial attendance to Major urban % patients 3.0 3.1 2.9 2.5 2.3
ophthalmologist visits per patient 1.0 1.0 1.0 1.0 1.0
Urban % patients 2.3 2.6 2.2 2.4 1.7
visits per patient 1.0 1.0 1.0 1.0 1.0
Rural % patients 1.8 1.3 2.2 1.4 2.0
visits per patient 1.0 1.0 1.0 1.0 1.0
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Table 3-2.    The difference (OR and 95% CI) in the proportion of patients with diabetes living in major urban, urban and
rural localities attending medical practitioners and undergoing diabetes related investigations for the individual
years 1993 to 1997, adjusted for age and gender
Service Region 1993 1994 1995 1996 1997
Attendance to specialist Major urban 1.22 (1.17 to 1.28) 1.17 (1.12 to 1.23) 1.04 (0.99 to 1.08) 1.13 (1.08 to 1.18) 1.15 (1.11 to 1.21)
Urban 1.08 (1.04 to 1.14) 1.09 (1.04 to 1.14) 1 (0.96 to 1.05) 1.09 (1.04 to 1.14) 1.12 (1.07 to 1.18)
Rural 1 1 1 1 1
Attendance to physician Major urban 1.85 (1.76 to 1.95) 1.6 (1.52 to 1.68) 1.51 (1.44 to 1.58) 1.82 (1.73 to 1.90) 1.68 (1.61 to 1.76)
Urban 1.16 (1.10 to 1.22) 0.98 (0.93 to 1.03) 1.01 (0.96 to 1.06) 1.2 (1.14 to 1.27) 1.12 (1.07 to 1.18)
Rural 1 1 1 1 1
Initial attendance to Major urban 1.6 (1.37 to 1.87) 2.31 (1.93 to 2.77) 1.28 (1.10 to 1.47) 1.73 (1.45 to 2.07) 1.14 (0.98 to 1.33)
Ophthalmologist Urban 1.2 (1.02 to 1.41) 1.95 (1.62 to 2.36) 0.94 (0.80 to 1.09) 1.6 (1.33 to 1.92) 0.85 (0.72 to 1.00)
Rural 1 1 1 1 1
Lipids * Major urban 2.11 (2.01 to 2.21) 1.83 (1.75 to 1.92) 1.49 (1.43 to 1.56) 1.29 (1.24 to 1.35)
Urban 1.1 (1.05 to 1.16) 1.11 (1.06 to 1.17) 1.01 (0.96 to 1.05) 0.91 (0.87 to 0.96)
Rural 1 1 1 1
HDL cholesterol * Major urban 1.35 (1.26 to 1.43) 1.3 (1.22 to 1.38) 1.19 (1.12 to 1.27) 1.21 (1.14 to 1.29)
Urban 0.92 (0.86 to 0.99) 0.95 (0.90 to 1.02) 1.07 (1.01 to 1.14) 1.12 (1.05 to 1.19)
Rural 1 1 1 1
HbA1c Major urban 1.12 (1.07 to 1.18) 1.09 (1.05 to 1.14) 1.17 (1.12 to 1.22) 1.05 (1.00 to 1.09) 0.89 (0.85 to 0.93)
Urban 0.92 (0.88 to 0.96) 0.93 (0.89 to 0.98) 1.12 (1.07 to 1.17) 1.09 (1.04 to 1.14) 0.93 (0.89 to 0.97)
Rural 1 1 1 1 1
Microalbuminuria * Major urban 2.27 (1.94 to 2.66) 1.29 (1.17 to 1.42) 1 (0.92 to 1.08) 0.9 (0.85 to 0.97)
Urban 1.87 (1.59 to 2.20) 1.05 (0.94 to 1.16) 0.87 (0.80 to 0.94) 0.91 (0.85 to 0.97)
Rural 1 1 1 1
*  Possible inaccuracy as the item codes used to retrieve data on lipids, HDL cholesterol and microalbuminuria were introduced during 1993 therefore
          this information is not listed
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The difference in the proportion of patients attending consultant
physicians was greater.  During 1997, 41.8% of individuals with diabetes
living in major urban areas attended a consultant physician compared to
28.8% and 29.4% of those in urban and rural areas.  As seen in Table 3-2,
the adjusted OR of the major urban group attending a physician reached as
high as 1.85 (95% CI: 1.76 to 1.95) when compared with their rural
counterparts.  Examination of service utilisation for the non-diabetic
population showed a similar pattern (OR: 1.88; 95% CI: 1.85 to 1.90).
The mean number of attendances to consultant physicians was also higher,
averaging 3.8 visits per patient per year in major urban areas and 3.3 visits
per patient per year for both urban and rural areas, a 1.2 fold increase.
The proportion of patients billed by an ophthalmologist for an initial
examination was extremely small for each locality.  In 1997, only 2.3% of
diabetic patients living in a major urban area were billed using the initial
examination item code 106, falling to 1.7% of diabetic individuals in
urban areas and 2.0% of individuals in rural areas.  Ophthalmologists
frequently bill using specialist item codes 104 and 105, which are shared
with specialists of other disciplines.  As seen previously, a large
proportion of people with diabetes were billed under these item codes.
Thus the proportion of patients in each locality under the care of
ophthalmologists may be significantly higher than indicated.
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Laboratory investigations
As seen in Table 3-3, the proportion of patients living in major urban
areas with an HbA1c estimation during 1993 was significantly greater than
the proportion in rural areas (36.1% versus 32.9%; adjusted OR: 1.12;
95% CI: 1.07 to 1.18).  By 1997, this had reversed with significantly
fewer patients in major urban areas undergoing this investigation  (55.2%
versus 57.4%; adjusted OR: 0.89; 95% CI: 0.85 to 0.93).  Although the
absolute number was much smaller, a similar pattern was seen for
monitoring of microalbuminuria with 3.9% versus 1.8% of patients in
major urban and rural areas undergoing this test in 1994 (adjusted OR:
2.27; 95% CI: 1.94 to 2.66) compared to 11.3% versus 12.3% in 1997
(adjusted OR: 0.90; 95% CI: 0.85 to 0.93).   The proportion of patients
undergoing cholesterol and HDL cholesterol estimation remained higher
in the major urban population throughout the study period. Overall, the
mean numbers of tests per individual were relatively similar between
localities (Table 3-3).  The monitoring of diabetes and its complications
using laboratory evaluations for both urban and rural areas improved
between 1993 and 1997, although it continued to fall short of the
standards of care recommended by the NSW Department of Health.
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Table 3-3. Frequency of laboratory investigations in persons with diabetes
living in major urban, urban and rural localities over the years
1993 to 1997
Service Region 1993 1994 1995 1996 1997
HbA1c * Major urban % patients tested 36.1 41.5 43.7 47.7 55.2
tests per patient 1.5 1.5 1.6 1.6 1.6
Urban % patients tested 31.8 37.5 42.7 48.6 56.1
tests per patient 1.5 1.5 1.5 1.5 1.5
Rural % patients tested 32.9 38.9 39.4 45.8 57.4
tests per patient 1.4 1.4 1.5 1.5 1.6
Lipids †§ Major urban % patients tested 45.3 47.6 50.4 52.7
tests per patient 1.5 1.6 1.6 1.6
Urban % patients tested 30.2 35.6 40.6 44.2
tests per patient 1.4 1.4 1.4 1.4
Rural % patients tested 28.0 32.7 39.8 45.8
tests per patient 1.4 1.4 1.5 1.4
HDL cholesterol †§ Major urban % patients tested 16.2 17.7 16.8 18.6
tests per patient 1.3 1.3 1.3 1.3
Urban % patients tested 11.7 13.6 15.3 17.4
tests per patient 1.2 1.3 1.3 1.3
Rural % patients tested 12.4 14.0 14.2 15.7
tests per patient 1.3 1.3 1.3 1.2
Microalbuminuria ‡§ Major urban % patients tested 3.9 6.3 8.0 11.3
tests per patient 1.1 1.2 1.2 1.2
Urban % patients tested 3.2 5.0 7.0 11.3
tests per patient 1.1 1.1 1.1 1.2
Rural % patients tested 1.8 4.9 8.0 12.3
tests per patient 1.2 1.2 1.1 1.1
NSW Health Department (1996) guidelines for the management of diabetes
* 1-4 tests per year
† Every 1 to 2 years if normal, every 3 to 6 months if abnormal or on treatment
‡ Every year
§ Possible inaccuracy as the item codes used to retrieve data on lipids, HDL Cholesterol and
   microalbuminuria were introduced during 1993 therefore information for this year is not
   listed
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Discussion
Routine monitoring of clinical status to promote optimal diabetes control,
regular screening to facilitate the early detection and appropriate
management of complications and access to specialist care for those
patients that require it have all been identified as key components of
effective diabetes care (Colagiuri et al, 1995).  While many people with
diabetes have access to this level of care, many do not.  As reported in
Chapter 2, large proportions of the diabetic population living in NSW are
not routinely monitored in regard to diabetes and its complications.  The
present study has shown that monitoring of patients in rural areas is also
less than adequate but the differences between rural patients and their city
counterparts were surprisingly small.  Standards of care did improve in all
parts of the State over the study period.  It is noteworthy, however, that
the improvement in the proportion of patients with an HbA1c or
microalbuminuria estimation each year was greatest in rural areas, despite
rural areas being serviced by less general practitioner per head of
population (Commonwealth Department of Health and Family Services,
1996).  Moreover, this improvement was achieved with fewer attendances
to the general practitioner and fewer patients attending secondary care.
In 1996, the NSW Department of Health widely disseminated clinical
guidelines for the management of diabetes.  As part of their dissemination
programme, diabetes specialists from major teaching hospitals were
employed to visit rural locations to provide background training in
diabetes care to the general practitioners working in these areas. Around
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the same time the General Practice Branch of the Commonwealth
Department of Health and Family Services established the Integration
Support and Evaluation Unit (Integration SERU).  As one of its first
initiatives, Integration SERU set up a network to change the focus of
diabetes programmes within Divisions of General Practice from providing
patient education to monitoring clinical outcomes.  Prior to these
initiatives the proportion of patients undergoing investigations for HbA1c
and microalbuminuria had been higher in the major urban population.
The education of general practitioners regarding the nuances of diabetes
care, together with the network system aimed at changing general
practitioners diabetes focus, may account, at least in part, for the notable
improvement in monitoring practice in rural areas. Of interest is the
finding that monitoring of lipids remained higher in the major urban
population throughout the study period.  This may reflect an emphasis
placed on diabetes specific rather than diabetes related complications in
the aforementioned training and support programs.
It is theoretically possible that geographical differences in the use of
diabetes related services are greater than has been demonstrated by this
study.  Medicare occasions of service data does not capture persons with
diabetes either receiving care through hospital based services or receiving
no care at all.  However, over recent decades there has been a trend
towards moving patients traditionally cared for by diabetic clinics back to
their general practitioner for ongoing care.  As seen in the previous
Chapter, a survey of all hospitals in NSW (n=198) showed that only about
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10,000 patients are retained under the traditional hospital model, with the
services spread across all localities.  This would not impact greatly on the
current findings.  It is also possible that a number of persons with diabetes
living in rural areas receive no medical care at all and are therefore not
identified by the Medicare data.  As seen in this study, the prevalence of
diabetes in rural areas, calculated using the number of individuals using
any Medicare service over the 5-year study period, was 0.5% lower than
that found in areas of higher population density.  While this is an
interesting phenomenon to be studied further, it should not cause a great
degree of distortion to the data.
Whether the differences in monitoring practice between areas of higher
and lower population density are reflected by improved health outcomes
cannot be addressed by this study as Medicare data is linked to service
utilisation only.  Over recent years several initiatives within NSW have
tried to monitor outcomes such as HbA1c and lipid levels but there remains
a paucity of representative data on patients cared for by general
practitioners, particularly those living in rural areas.  The issue of
accessibility and patient convenience has also not been fully addressed.
While the differentials in service utilisation for patients in rural areas were
surprisingly small, many of these patients would be required to travel long
distances to seek medical care.
Despite these caveats, this study has provided unique information on both
health service utilisation and standards of care for people with diabetes
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living in different localities in NSW.  It has served to highlight the
differentials in the access of specialist services for patients living in the
less densely populated areas.  The development of innovative models of
care that emphasise the coordination and cooperation among general
practitioners and specialists and provide outreach services may help
address these differentials (American College of Physicians, 1995).
However, as suggested by this study, ensuring other mechanisms such as
ongoing medical education are available to support general practitioners
manage their patients with chronic diseases may be an equally important
goal.
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Chapter 4
Diabetes management:
shared care or shared neglect
Introduction
The number of people with diabetes continues to escalate (Zimmet and
McCarty, 1995).  Simple calculations based on this number would dictate
that no hospital or specialist system could provide care to all patients with
diabetes without a significant increase in funds.  It is therefore important
to examine the different approaches to managing patients with this chronic
disease.  A system of ‘shared’ care between primary and secondary health
services is increasingly being advocated as a way of maximising efficacy
while minimising costs (Powel, 1991; Hoskins et al, 1993; Dunning et al,
1993).  The shared care approach encourages and supports general
practitioners to continue to manage their patients in the community while
facilitating access to specialised services for those patients who require
them.
The philosophy of diabetes shared care was first adopted by the Division
of General Practice and the Diabetes Centre of Royal Prince Alfred
Hospital, the Central Sydney Area Health Service (CSAHS), Sydney,
Australia, in the mid 1980s.  Under this model, it is the role of the general
practitioner to mediate movement of patients between the community and
specialist care when diabetes control deteriorates, when advice or
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treatment of diabetic complications is required or when sufficient time has
elapsed to warrant a complete diabetes review.  The role of the Diabetes
Centre is to provide specialised services that cover a spectrum of activities
ranging from patient education to clinical care to which general
practitioners can choose to refer.  To emphasise the complementarity of
primary and secondary care, the Diabetes Centre does not provide regular
follow-up.  It is an agreed tenet that patients are returned to their referring
doctor for ongoing care within 3 months of the initial referral.
Correspondence is sent to the general practitioner outlining treatment
recommendations that require implementation.  While they are invited to
consider referring patients back to the Diabetes Centre in 12 to 24 months
for a complication assessment, re-referral is left to their discretion.  If this
approach is to be effective, it is important to ensure that areas of diabetes
management are not neglected due to confusion of roles (Williams, 1995).
Therefore, the study reported in this Chapter aimed to evaluate shared care
in terms of whether specialist treatment recommendations are implemented
and if this affects diabetes outcomes.
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Method
A total of 1669 patients were referred to the Royal Prince Alfred Hospital
Diabetes Centre for assessment and clinical care between October 1993
and October 1995.  Using the Diabetes Centre's computerised database,
patients who were re-referred for a further assessment were identified.  A
total of 742 patients (44.5%) met this criterion.  From this group, a random
sample of 200 patients was selected and their records retrieved. The paper
and computer records for the 2 referrals, hereafter referred to as Visit 1 and
Visit 2, were audited for each patient.  Subsets of data were collected
regarding the patient, the referring general practitioner and the
correspondence to and from the referring doctor.
General practitioner data included the number of patients they had referred
to the Diabetes Centre within the last 2 years, whether the doctor was
enrolled with the CSAHS Diabetes Shared Care Programme and the type
of practice in which they worked (solo practice, group practice or medical
centre).  The initial referral letter was audited for length and content.
Correspondence from the Medical Director of the Centre was reviewed to
ascertain whether treatment recommendations had been given to the
referring general practitioner after Visit 1.  Explicit directives to
commence or adjust treatment were taken as a recommendation being
given.  For example, an instruction to ‘please commence this patient on an
HMG CoA reductase inhibitor’ or ‘please continue to increase the
Metformin to the maximal dose of 1 Gm tds’ was recorded as a treatment
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recommendation.    Information recorded at Visit 2 was used to assess
whether these recommendations had been implemented.  For example, the
recommendation was taken as implemented if the patient had commenced
an HMG CoA reductase inhibitor or the Metformin had been increased to
the maximal dose.
For the purpose of the audit, values obtained for glycosylated haemoglobin
levels (HbA1c), blood pressure determinations, lipid levels and retinopathy
status at Visit 1 and Visit 2 were collected as outcome data.  HbA1c had
been measured by HPLC (Biorad, CA, USA; CV < 2%).  Total cholesterol,
HDL cholesterol and triglycerides had been measured using the CHOD-
PAP method of enzymatic testing (Boehringer Mannheim. Mannheim,
Germany; CV < 1%).  Two blood pressure readings had been taken in a
sitting position and the mean result reported.  Examination of the optic
fundus had been performed with pupils dilated using a direct
ophthalmoscope by a single observer.
Statistical methods
The data was analysed using the Number Cruncher Statistical System
software package (Hintze, 1999).  Statistical methods for analysing paired
data were adopted when comparing Visit 1 and Visit 2 outcome data.
Unpaired statistical methods were adopted when analysing the data in
terms of whether patients had or had not had treatment recommendations
implemented.   Continuous data were analysed by t-tests and Mann
Whitney tests.  Categorical data was analysed by χ2 test.  Logistic
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regression was performed to determine independent predictors of a
recommendation being implemented, eliminating non-significant variables
from a base model which included all variables with a significance of 0.1
on initial analysis.  Results were regarded as significant at the P<0.05
(two-tailed) level.  Results are expressed as mean and standard deviation
(SD) for parametric data and frequency and percent, median and inter-
quartile range (IQR) for non-parametric data.
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Results
The median time between referrals for the 200 patients was 15 months
(IQR 13-18).  Most patients (87.5%) attended one general practitioner at
the time of referral and had been under the doctor's care for a median of 6
years (IQR 3-10 years); however, 27 patients (13.5%) changed doctors
between referrals.   Nearly half  (43%) attended a doctor formally
registered with the CSAHS Diabetes Shared Care Programme.
Overall, a total of 158 treatment recommendations were given for 110
patients (55%).  Recommendations were given regarding metabolic
control, blood pressure treatment and lipid treatment to 76 (38%), 29
(15%) and 38 (19%) patients respectively and referral to an
ophthalmologist was suggested in 15 (8%) patients.  As seen in Table 4-1,
general practitioners were less likely to implement lipid treatment
recommendations, although this did not reach significance.  There were no
significant differences in the mean age or duration of diabetes, gender or
ethnicity between patients who did and did not have treatment
recommendations implemented (Table 4-2).
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Table 4-1. Number of patients with treatment recommendations
implemented at Visit 2
Type of recommendation Recommendation
implemented
(n=86)
Recommendation
not implemented
(n=24)
Metabolic control
Blood pressure
Lipids
Eyes
Any recommendation
58 (76%)
22 (76%)
21 (55%)
11 (73%)
86 (78%)
18 (24%)
7 (24%)
17 (45%)
4 (27%)
24 (22%)
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Table 4-2. Demographic profile of patients who did and did not
have treatment recommendations implemented
Patient characteristic Recommendation
implemented
(n=86)
Recommendation not
implemented
(n=24)
Age (yrs)
Duration of diabetes (yrs)*
Male
Anglo-Celtic
Interpreter required
Duration of contact with the
referring doctor (yrs)*
No. of  general practitioners
59.9 (SD 10.0)
6 (3-10)
44 (52%)
55 (65%)
16 (19%)
5 (3-10)
1.1 (SD 0.3)
57.3 (SD 9.4)
5 (1-9)
12 (50%)
18 (75%)
4 (17%)
8 (3-20)
1.1 (SD 0.4)
Results expressed as mean (SD) except where indicated
* Median (IQR)
While change of doctor between referrals did not adversely affect
implementation of treatment recommendations (84.6% versus 77.3%, NS),
several other doctor-related factors emerged as having a significant effect.
Doctors involved with the Diabetes Shared Care programme were more
likely to implement treatment recommendations than their non-shared care
counterparts (87.2% versus 70.9%; χ2 (df-1)  = 4.12; P=0.04).  Doctors who
wrote longer referral letters were also more likely to implement
recommendations (median number of words: 56 [IQR: 36-71] versus 45
[IQR: 23-59]; P=0.02).  After adjusting for the content of the referral
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letter, whether the referring general practitioner was a shared care doctor
and the number of patients the doctor had referred in the last 2 years, the
length of the referral letter emerged as the only independent factor
associated with treatment implementation (χ2 (df-1)  = 5.40; P=0.02);
however, this only accounted for 7% of the variance.
As seen in Table 4-3, patients who had recommendations regarding
metabolic and lipid treatment implemented had significantly lower HbA1c
(P=0.04), cholesterol (P=0.0005) and triglyceride (P=0.05) levels at Visit
2 as compared to Visit 1.  The Visit 2 cholesterol of this group was also
significantly lower than that of patients in whom recommendations had
not been implemented (P=0.008).
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Table 4-3. Clinical profile of patients who did and did not have treatment recommendations implemented
Outcome           Recommendation implemented
                               (n=86)
            Visit 1                            Visit 2
       Recommendation not implemented
                                (n=24)
          Visit 1                                Visit 2
HbA1c (%)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Cholesterol (mmol/L)
Triglyceride (mmol/L)
HDL cholesterol
        8.4 (7.6-9.4)
        150 (137-160)
        90 (80-100)
        6.8 (6.2-7.3)
        2.8 (2.2-4.0)
        1.1 (0.9-1.4)
    7.6 (7.0-9.1) †
    147 (137-159)
    85 (80-90)
    5.6 (4.9-6.3)§ ¶
    2.0 (1.5-3.9) **
    1.1 (1.0-1.3)
        8.0 (7.7-9.5)
        164 (150-175)
        94 (90-100)
       6.5 (5.8-7.4)
       3.6 (2.9-4.6)
       1.1 (0.9-1.3)
        8.1 (7.8-9.4)
       158 (150-182)
       89 (80-92)
       6.5 (6.3-7.1)
       3.4 (2.3-5.4)
       1.0 (0.8-1.6)††
Results are expressed as median (IQR)
Different from Visit 1
†  P=0.04    §  P=0.0005   ** P=0.05     †† P=0.02
Different from recommendation not implemented
¶  P=0.008
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Discussion
The hypothesis that the standard of care will be maintained by the shared
care approach is a reasonable one and is supported by results of a clinical
trial conducted in the Central Sydney area in the late 1980s (Hoskins et al,
1993).   However, the success of shared care in 'real life' is not well
established.  If health care professionals within a shared care partnership
leave undone what they think is taken care of by others, shared care may
become ‘shared neglect’ (Williams, 1995). At least in the model described
in this Chapter this does not appear to be the case; the majority of
treatment recommendations made at the specialist level were implemented
by the general practitioner.   Unfortunately, due to the Australian health
system, patients can move from one area to another to seek medical care.
Moreover, under the CSAHS shared care model, patients do not routinely
return for specialist care and re-referral is left to the discretion of the
general practitioner.  Thus, whether recommendations have also been
implemented for patients who have not returned to the Diabetes Centre
since their initial assessment has not been addressed by this study.
For those patients returning for specialist review, the only area where
implementation rates were low was in regards to treatment of
dyslipidaemia.   Prior to 1995, regulations set down by the Australian
Government meant that cholesterol and triglyceride levels could not be
treated with pharmaceutical agents until the levels exceeded 6.5 mmol/L
and 4.0 mmol/L respectively, yet diabetes best practice guidelines
suggested treatment should be commenced at lower levels of abnormality.
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As some of the treatment recommendations were made prior to 1995, this
result may be a reflection of the prescribing threshold rather than a
reluctance to implement lipid treatment.  However, the finding that lipid
treatment is under-utilised in general practice is not a new one (Leitha et
al, 1994; McGill et al, 1993).
While the notion of 'diabetes shared care' has been widely adopted, it is
inevitable that different health services will have adopted their own system
of implementation.  Thus each system of shared care needs to be
independently tested and continually monitored.  What components of
shared care make each system 'work' or 'not work' also need to be
identified.  As seen in this study, doctors formally registered in the
CSAHS Diabetes Shared Care Programme implemented recommendations
more often than their non-shared care counterparts. Ongoing education,
ranging from detailed correspondence through to practically based training
days or after hour seminars, is an integral component of this programme.
However, in the CSAHS system, doctors not registered with the
programme can participate in all educational and clinical activities, thus it
is not possible to be certain that ongoing education accounts for this
finding.
Despite some recommendations not being implemented, the average
HbA1c of patients when returned to specialist care was 7.7%.  As
previously discussed, under the CSAHS shared care philosophy, it is the
role of the general practitioner to refer patients to specialist care when they
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deem it appropriate.  The NSW Department of Health recommends that
intervention is required when the HbA1c exceeds 2.0% from the upper limit
of normal.  Therefore, a rise in HbA1c to a level approaching 8.0% is an
appropriate trigger for referral and a reasonable use of specialist health
care resources.  Moreover, the HbA1c and complication profiles at time of
re-referral of the study cohort were similar to those found in a recent
Australian survey of 4,080 people receiving diabetes care under a variety
of diabetes care models (Flack and Colaguri, 1998).  Other studies
elsewhere in the world have reported average HbA1c values of 8.5%
(Hayward et al, 1997) and 9.0% (Dunn and Bough, 1996). Therefore, it
would seem that diabetes care provided under the shared care philosophy
compares favourably to that provided by many other approaches.
Failure of shared care to achieve a higher rate at which recommendations
are implemented may be the result of a number of reasons. While some
countries such as the United Kingdom conduct diabetes clinics at the
general practice level, in Australia, patients rarely present to their general
practitioner for treatment of diabetes alone.  This means that the
opportunity to commence or adjust treatment may be missed.  Moreover,
the majority of general practitioners in the Central Sydney Area work in
solo practice (Overland, 1996) and their patient load and time constraints
may affect their ability to implement treatment guidelines (Starfield,
1994).  Competition between doctors and the lack of government control
has also led to patients shopping around for general practitioners.  A
previous study conducted in the Central Sydney Area in the late 1980s
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found that 31% of patients with diabetes consulted more than one general
practitioner (Constantino et al, 1991).  The implication of this is that
communication outlining treatment recommendations may not be
forwarded to all the patients’ medical advisers; therefore, areas of
treatment may remain neglected.  Over recent years the Diabetes Centre
has tried to address this by emphasising to the patients the importance of
not changing doctors unnecessarily.  Hopefully, this is why the majority of
patients in this study (87.5%) only attended one general practitioner and
had been under the care of their referring doctor for several years.
The diverse characteristics of general practitioners make it difficult to
formulate treatment and follow up policies that suit all clinical situations
(Constantino et al, 1991).  While some are reluctant to implement
treatment changes, others are keen to take on this responsibility.  Ideally,
there should be a system of 'differential shared care’.  For patients of
doctors with extensive interest and experience in diabetes, the majority of
care is left in the hands of the general practitioner.  For patients of doctors
with less interest or experience in diabetes, the Diabetes Centre assumes a
more active role.  To date, the Diabetes Centre has relied heavily on
knowledge of the individual general practitioners (and vice versa) to select
the degree of shared care that is appropriate.  However, this approach is
highly subjective.  The results of this study would suggest that the length
of the referral letter might be an indicator of the referring doctors’
acceptance to implement treatment changes.  However, this only explains a
small degree of variation between referring doctors.  Therefore further
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study is needed to identify doctor characteristics that are associated with a
desire to be more active within the shared care partnership.
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Chapter 5
Shared care: does it promote the
optimal use of specialist care
Introduction
Shared care models have evolved to encourage and support general
practitioners to continue to manage their patients in the community while
facilitating access to specialised services for those patients who require
them. In many systems, a yearly review by the specialist is standard.
However, with the increasing number of people with diabetes, it is
unlikely that specialist services will be able to sustain these models.
Ideally, there should be a system of differential shared care, where
patients of doctors with extensive interest and experience in diabetes are
primarily managed by the general practitioner whereas the specialist plays
a more active role for patients of doctors with less interest or experience.
The model of shared care established by the CSAHS is based on the
principles of differential care.  As described in Chapter 4, under the
CSAHS model the general practitioner is the primary provider of diabetes
management and referral to specialist services is left to their discretion.
To emphasise the complementary nature of primary and secondary care,
the Diabetes Centre does not provide regular follow-up and patients are
returned to their referring doctor for ongoing care within 3 months of the
initial referral, although many are seen on several occasions during this
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period.  Detailed correspondence in a standardised format is sent to the
referring doctor outlining treatment recommendations that require
implementation.
To further prioritise the need of patients to see specialists, it is an agreed
tenet that patients are not recalled at regular intervals for review.  Instead,
general practitioners are invited to consider re-referral of their patients
back to the Diabetes Centre when metabolic control deteriorates, when
advice or treatment of complications is required or when sufficient time
has elapsed to warrant a complete diabetes review.  If this approach to
shared care is to be effective it is important to ensure that patients receive
the level of care they require and that standards of care are maintained for
all patients.  As shown in the previous Chapter, at least for patients
referred back for review, general practitioners are active within the shared
care partnership and implement the majority of treatment
recommendations made at the specialist level, resulting in favourable
glycaemic, lipid and blood pressure profiles.  However, data is obviously
lacking for those patients whose care is kept at the primary care level.
This current study therefore sought to trace patients who have not been
referred back for specialist review and compared them to a group of
patients who had been re-referred.  Factors such as patient and doctor
characteristics and treatment recommendations at initial consultation were
examined.
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Methods
A total of 1669 individual patients were referred to the Royal Prince
Alfred Hospital Diabetes Centre for assessment and clinical care in a 2-
year period. Some of these patients would subsequently have been
referred for a repeat assessment.  Using the Diabetes Centre computerised
database, lists of returned and non-returned patients were generated,
ordered by date of attendance, and the clinical status of each patient was
retrieved.  A stratified sample of 200 returned and 200 non-returned
patients was obtained by selecting every 4th patient from each list.
The paper and computer records of the initial visit for each selected
patient were audited.  Data were collected regarding the patient, the
referring general practitioner and the correspondence to and from the
referring doctor.  For the purpose of this study, values obtained for HbA1c,
blood pressure determinations and lipid levels were collected as clinical
data.  HbA1c had been measured by HPLC (Biorad, CA, USA; CV < 2%).
Total cholesterol, HDL cholesterol and triglycerides had been measured
using the CHOD-PAP method of enzymatic testing (Boehringer
Mannheim. Mannheim, Germany; CV < 1%).  Two blood pressure
readings had been taken in a sitting position and the mean result reported.
General practitioner data collected included the number of patients they
had referred to the Diabetes Centre within the last two years, whether the
doctor was enrolled with the Diabetes Shared Care Programme and the
type of practice in which they worked (solo practice, group practice or
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medical centre).  The referral letter was audited for length and content.
Correspondence from the Medical Director of the Centre was reviewed to
ascertain what specific treatment recommendations had been given to the
referring general practitioner.  Explicit directives to commence or adjust
treatment were taken as a recommendation being given.  For example, an
instruction to ‘please commence this patient on an HMG CoA reductase
inhibitor’ or ‘please continue to increase the Metformin to the maximal
dose of 1 Gm tds’ was recorded as a treatment recommendation.
For the returned patient group, information recorded at their return
assessment was used to assess whether these recommendations had been
implemented.  For example, the above recommendations were taken as
implemented if the patient had commenced an HMG CoA reductase
inhibitor or the Metformin had been increased to the maximal dose.
For the non-returned patients, a letter and questionnaire was forwarded to
the referring doctor.  For those patients in whom a treatment
recommendation had been made, the doctor was asked to review the
patient’s medical records and to provide details regarding whether the
recommendation had been implemented.  A stamp addressed envelope
was included to expedite return of the questionnaire (Appendix 2) and
general practitioners were thanked by a promise to have their names put in
a draw for a dozen bottles of wine upon receipt of the completed
questionnaire.  The doctors were not asked to re-refer the patient for a
repeat assessment as this would have been a breach of the CSAHS shared
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care agreement.  The patient may also have moved to the care of another
doctor.
To maximise data completion for the non-returned group, a letter was also
forwarded to the patients informing them that the staff of the Diabetes
Centre would be contacting them in the following week by telephone
(Appendix 2). The telephone directory was used to trace patients no
longer residing at their last known address.  During telephone contact, the
patients were questioned regarding the general practitioner(s) they were
currently attending.  Details were also collected in terms of whether
treatment recommendations given at the initial consultation at the
Diabetes Centre had been implemented.
Statistical methods
The data were analysed using the Number Cruncher Statistical System
software package (Hintze, 1999).  Attempts were made to normalise non-
parametric data.  Where this was not possible, non-parametric tests were
used.  Continuous data were analysed by unpaired t-tests and Mann-
Whitney tests.  Categorical data were analysed by χ2 test.  Logistic
regression was used to determine independent predictors of patients
returning for specialist review, eliminating non-significant variables from
a base model which included all variables with a significance of 0.1 on
initial analysis.  Interaction terms were included in the base model to
assess for potential interaction between independent predictors. Results
were regarded as significant at the P<0.05 (two-tailed) level.  Results are
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expressed as mean and standard deviation (SD) for parametric data and
frequency and percent, median and inter-quartile range (IQR) for non-
parametric data.
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Results
The 400 patients selected for this study had been initially referred by 216
individual general practitioners.  Doctors formally enrolled in the Diabetes
Shared Care Programme referred significantly more patients to the
Diabetes Centre over the past 2 years (median: 11.5, IQR: 4.8 to 14.5
versus median: 2; IQR, 1 to 5; P=0.00001) than their non-shared care
counterparts.  However, a higher proportion of shared care doctors (52.5%
versus 21.3%; χ2 (df-1)=16.5; P=0.00005) were selective in whom they
returned for specialist review, choosing to re-refer some patients and not
others.
General practitioners completed 165 questionnaires (82.5%) and 127
patients (63.5%) were successfully contacted via the telephone. Overall,
information on 182 of the 200 (91%) non-returned patients could be
obtained.  Comparison of responses where information was available from
both doctor and patient showed 100% agreement.  Seventeen of the non-
returned patients were deceased, representing 4.5% of the total cohort.
As seen in Table 5-1, there were no significant differences in the
glycaemic, blood pressure and lipid levels of returned and non-returned
patients at the initial consultation.  However, non-returned patients were
less likely to have a history of macrovascular disease or risk factor
(adjusted OR: 0.4; 95% CI: 0.2 to 0.6) (Table 6-2). Even after adjusting
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for the less complicated nature of these patients using a dichotomous
variable within the logistic regression model, they were given
significantly less treatment recommendations (adjusted OR: 0.5; 95% CI:
0.3 to 0.7).  Although there was no differences in the length of the letter
from referring general practitioners (50 words, IQR: 31 to 78 versus 48.5
words, IQR: 30 to 70), letters of non returned patients were more likely to
contain details of the patients type and/or duration of diabetes (adjusted
OR: 4.6; 95% CI: 2.5 to 8.4). Nearly half (47.1%) of non-returned patients
changed their general practitioner in the years following their assessment
at the Diabetes Centre.    In many cases (47.2%), the change was due to
the patient or doctor moving their address.  This movement between
doctors increased by 5 fold the likelihood of a patient not being re-referred
(adjusted OR: 5.0; 95% CI: 2.9 to 8.8). These 4 factors accounted for 23%
of the variance in determining whether a patient was re-referred.  Persons
with Type 1 diabetes were also less likely to return for specialist review,
however, this was not an independent predictor of a patient’s returned
status (adjusted OR: 0.7; 95% CI: 0.2 to 2.1).
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Table 5-1. Clinical profile of patients who did and did not return
for specialist review
Returned
n=200
Non returned
n=200
HbA1c (%)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Cholesterol (mmol/L)
Triglyceride (mmol/L)
HDL cholesterol (mmol/L)
7.8 (6.7-9.2)
137 (120-150)
80 (70-85)
5.5 (4.8 to 6.3)
2.0 (1.4-2.9)
1.18 (0.94-1.40)
7.8 (6.7-9.7)
130 (120-150)
80 (70-90)
5.6 (4.9-6.2)
1.9 (1.3-3.1)
1.17 (0.99-1.45)
Results are expressed as median (IQR)
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Table 5-2. Demographic profile of patients who did and did not
return for specialist review
Returned
n=200
Non returned
n=200
Age  (yrs)
Male
Type 2 diabetes *
Duration of diabetes (yrs)
Anglo-Celtic
History of macrovascular
disease or risk factor †
Duration of contact with
referring doctor (yrs)
Changed doctor after
Assessment 1 ‡
Type of practice attended
    Solo
    Group
     Medical Centre
57.7 (SD: 11.9)
51.0%
97.0%
6 (IQR: 2-10)
62.5%
78.0%
6 (IQR: 2.5 to 10)
13.5%
111 (55.5%)
49  (24.5%)
40  (20.0%)
57.1 (SD: 13.5)
59.0%
90.5%
4 (IQR: 1-10)
59.5%
49.0%
6 (IQR: 3-10)
47.1%
100 (50.0%)
62 (31.0%)
38 (19.0%)
* χ2  (df-1) =7.2; P=0.007
† χ2  (df-1) =36.3; P<0.00001
‡  χ2 (df-1) = 52.1; P<0.00001
Overall, a total of 236 specific treatment recommendations were given in
169 patients (42.3%). Recommendations were given regarding metabolic
control, blood pressure treatment and lipid treatment to 109 (27.3%), 49
(12.3%) and 55 (13.8%) patients, respectively, and referral to an
ophthalmologist was suggested in 23 (5.8%) patients.  As seen in Table 5-
3, significantly more treatment recommendations were given for patients
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who were subsequently re-referred.  The majority of recommendations
were implemented in both groups.  However, general practitioners
implemented more treatment recommendations in the non-returned group,
with the difference in implementation rate for metabolic recommendations
reaching statistical significance (χ2 (df-1) = 4.8; P=0.03).
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Table 5-3. Number of treatment recommendations implemented in returned and non-returned patients
Type of recommendation                 Recommendation given
    Returned                            Non returned
   Recommendation implemented
     Returned                               Non returned
Any recommendation
Metabolic control
Blood pressure
Lipids
Eyes
    110 (55%) *                        59 (29.5%)
     76 (38%) †                         33 (16.5%)
     30 (15%)                            19   (9.5%)
     38 (19%) ‡                         17   (8.5%)
     15  (7.5%)                            8      (4%)
    86 (78%)                                 50 (85%)
    58 (76%) §                              31 (94%)
    22 (73%)                                 15 (79%)
    17 (45%)                                 12 (71%)
      4 (27%)                                   7 (88%)
*  χ2  (df-1) =26.7; P<0.00001
†  χ2 (df-1) = 23.3; P<0.00001
‡  χ2 (df-1) = 9.3; P=0.002
§  χ2 (df-1) = 4.8; P=0.03
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Discussion
It is a reality that most health systems around the world need to provide
care to the growing number of people with diabetes without corresponding
increases to their budget.  It is therefore important to establish models of
care that optimise the use of finite resources.  In Australia, as in many
other countries, specialist services are less accessible and more expensive
than those provided by generalists.  Therefore models that share the care
of diabetic patients between general practitioners and specialists have
become increasingly popular.  However, there are no fixed criteria of what
constitutes shared care and, in particular, how often the specialist should
see the patient.  In many systems, a yearly review by the specialist is
standard.   However, when resources continue to contract, even providing
this could be difficult.  It is estimated that in the Central Sydney Area,
which serves a population of about 300,000 people, 40 specialist sessions
per week would be required for each patient to receive a specialist review
once a year.  Therefore, rather than providing a strict protocol for re-
referral, the CSAHS has adopted a differential approach that is dependent
on general practitioners providing the majority of diabetes management
and referring to specialist care only those patients they consider to require
it.  The results of this study suggest many general practitioners are
comfortable with this approach and are already caring for patients with
variable levels of diabetic control and vascular risk factors in a differential
manner.  Most importantly, they distinguish the level of care that patients
require.  As shown by these findings, general practitioners differentiate
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between the ‘more complicated’ patients, choosing to re-refer those with
macrovascular disease, while maintaining the care of ‘less complicated’
patients.  Although control of blood glucose levels can reduce
microvascular complications, it is the aggressive treatment of
macrovascular risk factors that significantly reduces the morbidity and
mortality associated with diabetes (Pyorala et al, 1997; UK Prospective
Diabetes Study (UKPDS) Group, 1998c).  Referral of patients with
macrovascular disease would therefore seem an appropriate use of
specialist services.
In addition to the patients’ macrovascular status affecting re-referral for
specialist care, multivariate analysis identified several doctor-related
factors as also having an affect.  Interestingly, general practitioners were
more likely to include details regarding type and duration of diabetes in
the referral letters of patients who were not re-referred for specialist
review.  This may reflect that these patients have less vascular risk factors,
thus issues relating to glycaemic control become more eminent in the
doctor’s mind.  Re-referral for specialist review was also dependent on the
patient remaining under the care of their original doctor.  A disturbingly
large proportion of the patients changed their general practitioner in the
years following their assessment at the Diabetes Centre.  The Central
Sydney Area has a highly mobile population and in many cases this
change in doctor was associated with change in the patients’ or doctors’
address.  Due to the Australian health system, patients can also move from
one area to another to seek medical care.  While many patients like to
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develop a relationship with their doctor over time, others are happy to
attend the most convenient doctor at the time of their need.  The practical
implication of this finding is, of course, that areas of diabetes management
may remain neglected.  Fortunately, in the majority of cases the treatment
recommendations had been implemented by the referring general
practitioner before the patient left their care. This study sought
information from both the referring general practitioner and patient.
Comparison of responses showed 100% agreement, thus it is unlikely that
the results have overestimated the rate at which these recommendations
were implemented.  These findings emphasise the importance of sending
correspondence to the referring doctors as soon as possible.  The Diabetes
Centre now also routinely sends a copy of the letter to the patient to
increase the chance of any new doctor becoming familiar with the
patient’s diabetic status and treatment requirements.
Also of interest is the finding that the doctors involved in the formalised
shared care programme referred more patients but were selective in whom
they re-referred for specialist care.  They provided ongoing management
for the majority of their patients following the initial specialist review but
re-referred those with macrovascular disease.  On the other hand, ‘non-
shared care’ general practitioners tended to re-refer all their patients,
regardless of whether they had a co-morbidity.  This ‘selectivity’ in
referral behaviour may be partly due to continued education, an
assumption supported by earlier work that suggested referral could be
influenced by the training and skills of general practitioners (Mudge
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1993).  However, doctors who choose to formally register with the shared
care programme may also be self selected in their commitment to the
shared care philosophy and may have more experience with diabetes care.
While there are limitations of any diabetes care model, this study has
shown that a system of differential shared care can provide flexibility so
that patients can receive the level of care they and their general
practitioner require.  Through encouraging selective referral to specialist
services, shared care can help to maximise the use of limited health care
resources, without compromise to standards of care.
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Chapter 6
Continuity of care
Introduction
Over the past few decades, general practice has changed with the advent
of increased competition, more stringent government control and the
demand for faster patient throughput to keep general practice
economically viable. While general practitioners remain the best placed
health professional to take an overall view of the health of person with
chronic disease, it takes a great deal of time to care for these patients.
These combined factors mean that the provision of best practice medicine
is not easy to accommodate within a single appointment.  In this pressured
environment, continuity of care becomes an important issue.  This is
especially so for patients with a chronic disease such as diabetes as they
require ongoing monitoring of glycaemic, lipid and blood pressure control
and adjustment of medication to deter the development or slow the
progression of diabetes complications.  A study of patients attending the
Royal Prince Alfred Hospital Diabetes Centre, Sydney, conducted in the
late 1980s, found that as many as 31% of people with diabetes attend
more than one general practitioner; some attending as many as 3 or 4
different practices (Constantino et al, 1991).  The staff of the Diabetes
Centre has since taken every opportunity to emphasise to patients the
importance of continuity of care.  In light of this, it is important to assess
the current status.  This study therefore sought to compare the
113
demographic profile and clinical outcomes of patients attending one
versus multiple general practitioners.  The profiles of patients who had
recently changed their general practitioner, compared to patients under the
care of their general practitioner longer term were also examined.
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Methods
Clinical assessment
In the system of diabetes care provided by the Royal Prince Alfred
Hospital Diabetes Centre, patients are referred by general practitioners for
clinical assessment, including assessment of diabetic complications. For
the purpose of this study, all data were collected on a standardised
assessment form (Appendix 3). Venous blood was taken for measurement
of HbA1c, total cholesterol, HDL cholesterol and triglycerides. A spot
sample of urine was collected and assayed for urinary albumin and urinary
protein.  Two blood pressure readings were taken in the sitting position
and the mean result used in the analysis. Vibration perception was
measured in a semi-quantifiable manner using a biothesiometer.  The
dorsalis pedis and posterior tibial pulses were palpated, and if absent, a
hand held Doppler was used for detection.  Optic fundus was examined
with pupils dilated using a direct ophthalmoscope.
For the purpose of statistical calculation, retinopathy was defined as
evidence of any retinopathy due to diabetes.  Microalbuminuria and overt
proteinuria were defined as urinary albumin concentration greater than 50
mg/L and 0.3 Gm/L respectively.  Neuropathy was defined as a
biothesiometer reading of greater than 40 volts.  Any complication of
diabetes was defined as having at least one of the following:
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cerebrovascular disease, ischaemic heart disease, peripheral vascular
disease, retinopathy, neuropathy, nephropathy or microalbuminuria.
Patients
Assuming 31% of patients attended more than one general practitioner
(Constantino et al, 1991), it was estimated that a sample size of 470
patients had 86% power of detecting a 15% difference in the proportion of
patients with a diabetes-related complication at the 0.05 significance level.
This sample size also had 85% power of detecting a 0.6% difference in
HbA1c concentration (ie. an HbA1c of 8.0% versus 7.4%), at the two sided
5% significance level, given a standard deviation of 2.0.  Consequently,
479 consecutive patients newly or re-referred to the Diabetes Centre in a
6-month period were studied and underwent the clinical assessment
described above. In addition to the assessment, the patients were
questioned regarding the number of general practitioners they attended
and the length of time they had been under the care of the referring doctor.
Statistical methods
Statistical analysis was performed using the Number Crunching Statistical
System software package (Hintze, 1999). Attempts were made to
normalise non-parametric data.  Where this was not possible, non-
parametric tests were used.  Separate analyses were performed for the 2
outcome variables of interest: the number of general practitioners attended
and the length of time under the referring general practitioner.  For the
purpose of analysis, patients were characterised as seeing either single or
multiple general practitioners.  Length of time under the care of the
116
referring doctor was categorised into 3 groups: less than 12 months, 1 to
10 years and more than 10 years. Continuous data were analysed by
unpaired t-tests, Mann-Whitney tests and One Way Analysis of Variance
(ANOVA).  Categorical data were analysed by χ2 test.  The Mantel-
Haenszel trend test (Armitage and Berry, 1990) was used to examine the
relationship between the proportion of persons with complications of
diabetes and length of time under the referring doctor.  Logistic
Regression was used to adjust for confounding variables.  Results were
regarded as significant at the P<0.05 (two-tailed) level.  Results are
expressed as mean and standard deviation (SD) for parametric data and
percent or adjusted odds ratio (OR) and 95% confidence interval (95% CI)
and median and inter-quartile range (IQR) for non-parametric data.
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Results
Single versus multiple general practitioners
Most patients (87.7%) attended only one general practitioner and had been
under the care of the referring doctor for a median of 6.2 years (IQR: 2.3-
12.1).  As seen in Table 6-1, patients who reported attending only one
general practitioner were older (median of 59.9 years versus 54.0 years;
P=0.02).  However, they were comparable with those attending multiple
general practitioners in terms of type and duration of diabetes as well as
length of time under the care of the referring doctor.  Their HbA1c, lipid,
blood pressure and treatment profiles were also similar.  Moreover, there
was no significant difference in the proportion of patients with the micro-
or macro-vascular complications associated with diabetes (Table 6-2).
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Table 6-1. Demographic and clinical profiles of patients under
the care of one versus multiple general practitioners
Attends one
general practitioner
n=430
Attends multiple
general practitioners
n=49
Age (yrs) †
Male
Anglo-Celtic
Time under referring
doctor (yrs)
Duration of diabetes (yrs)
Type 2 diabetes
Diabetes treatment
  Diet
  Tablets
  Insulin(+/- tablets)
Antihypertensive treatment
Lipid treatment
HbA1c (%)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Cholesterol (mmol/l)
Triglyceride (mmol/L)
HDL cholesterol (mmol/L)
59.9 (50.7 to 67.0)
51.6%
35.6%
6.3 (2.4 to 12.2)
5.4 (1.6 to 11.2)
95.1%
18.6%
63.7%
17.7%
43.0%
28.6%
7.8 (6.6 to 9.1)
135 (121 to 148)
80 (70 to 85)
5.2 (4.6 to 6.0)
1.9 (1.3 to 2.9)
1.1 (0.9 to 1.3)
54.0 (48.7 to 61.5)
46.9%
36.7%
5.3 (1.2 to 10.2)
5.2 (1.6 to 9.8)
100%
18.4%
67.3%
14.3%
36.7%
28.6%
7.5 (6.6 to 9.6)
130 (120 to 141)
79 (70 to 84)
5.3 (4.9 to 6.0)
2.4 (1.6 to 3.1)
1.0 (0.8 to 1.2)
Results are expressed as percent (%) and median (IQR)
†  Wilcoxin Rank-Sum; P=0.02
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Table 6-2. Complication profile of patients under the care of one versus multiple general practitioners
Attends one
general practitioner
n=430
Attends multiple
general practitioners
n=49
Cerebrovascular disease
Ischaemic heart disease
Peripheral vascular disease
Retinopathy
Neuropathy
Nephropathy (>0.3 Gm/L)
Microalbuminuria (>50 mg/L)
Any complication
6.5% (4.2% to 8.8%)
18.8% (15.1% to 22.5%)
1.4% (0.3% to 2.6%)
16.0% (12.6% to 19.5%)
15.5% (12.1% to 19.0%)
11.8% (8.2% to 15.4%)
23.3% (19.2% to 27.5%)
50.7% (46.0% to 55.4%)
6.1% (-0.6% to 12.8%)
16.3% (6.0% to 26.7%)
0
16.3% (6.0% to 26.7%)
12.2% (3.1% to 21.4%)
9.8% (0.7% to 18.8%)
22.9% (11.0% to 34.8%)
51.0% (37.0% to 65.0%)
      Results are expressed as proportion (95% CI)
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Time under the care of the referring general practitioner
There was also a relationship between the age of the patients and the
length of time they had been under the care of the referring doctor.  As
seen in Table 6-3, patients who had been attending the referring doctor for
one year or more were older than those patients who had only recently
changed their general practitioner (P=0.0002).  There was also a
progressive increase in duration of diabetes, although this did not reach
significance.
There were no differences in HbA1c, lipid, blood pressure and treatment
profiles for patients attending referring doctors for the different lengths of
time (Table 6-4).  However, the proportion of patients with a history of
cerebrovascular disease (test for trend: χ2 (df-1)  = 6.2; P=0.01), ischaemic
heart disease (test for trend: χ2 (df-1)  = 10.0; P=0.002) or any complication
of diabetes (test for trend: χ2 (df-1)  = 7.5; P=0.006) increased in a step-wise
fashion with each incremental increase in the length of time the patients
had been under the referring doctor’s care (Table 6-5).   As seen in
Figures 6-1 to 6-3, these upward trends remained continuous even when
the length of time under the care of the referring doctor was categorised
into smaller increments.
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Table 6-3. Demographic profile of patients under the care of the referring doctor for less than 12 months, 1 to 10 years and
more than10 years
Under the care of the
referring doctor for less than
12 months
n=67
Under the care of the
referring doctor for 1 to 10
years
n=221
Under the care of the
referring doctor for more
than 10 years
n=169
Age (yrs) †
Duration of diabetes (yrs) *
Type 2 diabetes
Male
Anglo-Celtic
No. of  general practitioners
Diabetes treatment
  Diet
  Tablets
  Insulin (+/- tablets)
Antihypertensive treatment
Lipid treatment
52.2 (SD 13.6)
3.4 (0.4 to 9.2)
92.5%
46.3%
35.8%
1.2 (SD 0.4)
22.4%
61.2%
16.4%
34.3%
25.4%
59.1 (SD 12.9)
5.1 (2.0 to 10.4)
96.4%
53.4%
33.9%
1.2 (SD 0.5)
18.6%
64.7%
16.7%
43.0%
30.3%
59.3 (SD 10.8)
6.7 (1.5 to 12.1)
95.9%
52.6%
36.7%
1.1 (SD 0.3)
16.6%
66.3%
17.2%
44.3%
27.8%
Data regarding length of time under the referring doctor is missing for 22 patients
†    ANOVA P=0.0002
*    Results are expressed as median (IQR)
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Table 6-4. Clinical profile of patients under the care of the referring doctor for less than 12 months, 1 to 10 years and more
                             than 10 years
Under the care of the
referring doctor for less
than 12 months
n=67
Under the care of the
referring doctor for 1 to 10
years
n=221
Under the care of the
referring doctor for more
than 10 years
n=169
HbA1c (%)
Systolic BP (mmHg)
Diastolic BP(mmHg)
Cholesterol (mmol/l)
Triglyceride (mmol/l)
HDL cholesterol (mmol/l)
7.3 (6.3 to 9.0)
130 (120 to 140)
80 (70 to 89)
5.5 (4.5 to 6.1)
2.0 (1.4 to 2.8)
1.1 (0.9 to 1.4)
7.8 (6.6 to 9.1)
135 (120 to 147)
79 (70 to 84)
5.3 (4.8 to 5.9)
1.9 (1.3 to 3.0)
1.1 (0.9 to 1.3)
7.8 (6.6 to 9.4)
135 (123 to 147)
80 (70 to 85)
5.2 (4.5 to 6.2)
1.9 (1.3 to 3.1)
1.1 (0.9 to 1.3)
Data regarding length of time under the referring doctor is missing for 22 patients
Results expressed as median (IQR)
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Table 6-5. Complication profile of patients under the care of the referring doctor for less than 12 months, 1 to 10 years
and more than 10 years
Under the care of the
referring doctor for less than
12 months
n=67
Under the care of the
referring doctor for 1 to 10
years
n=221
Under the care of the
referring doctor for more
than 10 years
n=169
Cerebrovascular disease †
Ischaemic heart disease ‡
Peripheral vascular disease
Retinopathy
Neuropathy
Nephropathy (>0.3Gm/L)
Microalbuminuria (>50 mg/L)
Any complication §
1.6% (-1.5% to 4.7%)
7.9% (1.3% to 14.6%)
1.7% (-1.6% to 4.9%)
17.5% (8.1% to 26.8%)
9.7% (2.3% to 17.0%)
9.5% (0.6% to 18.4%)
17.2% (8.9% to 29.1%)
38.7% (26.6% to 50.8%)
5.0 % (2.1% to 7.8%)
17.2% (12.2% to 22.2%)
0.9% (-0.3% to 2.2%)
14.5% (9.8% to 19.1%)
16.9% (11.9% to 21.9%)
12.1% (7.0% to 17.2%)
24.2% (18.3% to 30.0%)
51.1% (44.5% to 57.7%)
9.5% (5.0% to 13.9%)
24.9% (18.3% to 31.4%)
1.8% (-0.2% to 3.9%)
17.8% (12.0% to 23.5%)
14.4 % (9.1% to 19.7%)
12.7% (6.9% to 18.5%)
25.2% (18.5% to 31.8%)
56.8% (49.4% to 64.3%)
  Data regarding length of time under the referring doctor is missing for 22 patients
  Results are expressed as proportion (95% CI)
†    Test for trend:  χ2 (df-1)  = 6.2; P=0.01
‡    Test for trend: χ2 (df-1)  = 10.0; P=0.002
§    Test for trend: χ2 (df-1)  = 7.5; P=0.006
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Figure 6-1.     The proportion of patients with a history of cerebrovascular
                       disease, stratified by the time they had been under the referring
                       general practitioner
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Figure 6-2.     The proportion of patients with a history of ischaemic heart
                       disease, stratified by the time they had been under the care of
                       The general practitioner
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Figure 6-3. The proportion of patients with any complication, stratified by
the time they had been under the care of the referring general
practitioner
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Logistic regression models were performed to adjust for differences in the
patient’s age and duration of diabetes.  Both variables confounded the
trends associated with cerebrovascular disease or any complication of
diabetes. However, even when adjusted, there was a 3 fold increase
(adjusted OR: 3.23; 95% CI: 1.19 to 8.74) in the number of patients
attending the referring doctor for more than 10 years with a history of
ischaemic heart disease (Table 6-6).
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Table 6-6. The OR (95% CI) of a patient having a history of cerebrovascular disease, ischaemic heart disease or any
complication of diabetes, adjusted for age and duration
Cerebrovascular disease Ischaemic heart disease Any complication of diabetes
Under the care of the referring
doctor for less than 12 months
Under the care of the referring
doctor for 1 to 10 years
Under the care of the referring
doctor for more than 10 years
1
2.42 (0.29 to 19.78)
4.83 (0.61 to 38.29)
1
1.95 (0.72 to 5.30)
3.23 (1.19 to 8.74)
1
1.48 (0.81 to 2.70)
1.75 (0.94 to 3.26)
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Discussion
Within the Australian health system patients are relatively free to move around to
seek medical care.  While some patients like to develop a relationship with their
doctor over time, many frequently change their general practitioner or regularly
attend more than one general practitioner for the same health problem
(Commonwealth Department of Health and Family Services, 1996).  The
perception that many patients with diabetes shop around for a doctor was
confirmed by a study conducted by the Royal Prince Alfred Hospital Diabetes
Centre in the late 1980’s (Constantino et al, 1991). The finding from the current
study that the overwhelming majority of patients were under the care of a single
general practitioner and had been so for many years indicated that continuity of
care had improved.  The Central Sydney Area, in which this study was
conducted, is serviced by over 400 general practitioners.  In this relatively open
medical market, patients can readily use their exit option and seek care elsewhere
if incompatibility problems between patient and doctor existed. Hjortdahl and
colleagues (1992) found that continuity of care and patient satisfaction are bi-
directionally related.  This would imply that there is a reasonable degree of
satisfaction with the service patients in this study received.
Obviously the importance of diligent and continuous care increases as the
patients’ needs become more complex with increasing age and the clustering of
macrovascular risk factors such as dyslipidaemia and hypertension.  It makes
sense that younger patients who are relatively healthy apart from the presence of
diabetes, and are more likely to be working, would visit the closest doctor to
minimise work disruption, attending more than one general practitioner or
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frequently changing the regular doctor they see.   The lack of continuity seemed
to make little difference to acute outcomes such as glycaemic and blood pressure
control.  Presumably treatment of these areas is easier to address within several
consultations if the patients are relatively uncomplicated.  On the other hand,
older, more complicated patients generally need multiple drugs and considerable
efforts from both the patient and health care provider are required to achieve
maximal therapeutic benefit.  This increased patient-doctor dependency is most
clearly illustrated in this study by the relationship between longer duration of
contact and the increasing prevalence of diabetes complications, mainly
macrovascular disease.  Of note is the absence of a similar relationship in regard
to the complications specific to diabetes such as retinopathy and nephropathy.
Although general practitioners play an important role in the prevention and
detection of these complications, their treatment is often outside the general
practitioners’ domain.  As such, these patients are likely to be under the care of
one or more specialist practitioners and therefore have less of a dependency on
the general practitioner for ongoing medical care.
The data used in this study has been derived from patients referred by general
practitioners to a diabetes centre located within a major teaching hospital.  This
sample may be biased as patients who do not seek continuity of care from a
general practitioner may have less opportunity to be referred and are more likely
not to attend appointments which they had made (Sweeney and Gray, 1995).
Therefore the extent to which patients continue to doctor shop may be greater
than reported by this study.  However, this effect is probably quite small as
previous work has shown the patients referred to the Royal Prince Alfred
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Hospital Diabetes Centre are representative of persons with diabetes in the area as
a whole.
While the data are only observational in nature, they provide useful information
on the relationship between diabetes outcomes and continuity of care.  As seen in
this study, both patients and doctors are working appropriately, with continuity of
care improving especially once the patients’ medical requirements become more
complicated.  This is not only important medically, but also economically.
Without this continuity of care, the use of health care resources is likely to
increase (Hjortdahl and Borchgrevink, 1991) and therefore health costs.
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Chapter 7
Concluding remarks
Diabetes is certain to be one of the most challenging health problems facing all
nations this century.  However, mounting research is providing us with the tools
to reduce the personal and economic burden of this chronic disease.  Routine
monitoring of clinical status to promote optimal diabetes control and regular
screening to facilitate the early detection and appropriate management of diabetes
complications are now recognised as important cornerstones of effective diabetes
management.  As shown in the earlier Chapters of this thesis, large proportions of
people with diabetes are still not routinely monitored in regard to diabetes and its
complications.  While there have been improvements over time, most notably for
patients living in rural areas, further strategies will be required to continue this
momentum. The development of innovative models of care together with the
provision of mechanisms such as ongoing medical education to support
practitioners manage patients with chronic disease are possible vehicles with
which to drive further improvements.
Although it is probably inevitable that general practitioners would supervise most
aspects of the patient’s diabetes management, as seen in Chapters 2 and 3 of this
thesis, large proportions of patients with diabetes currently receive care at the
consultant physician level. The importance of access to this level of care for some
aspects of diabetes treatment is difficult to dispute.  Therefore, initiatives capable
of optimising access to specialist care need to be established.  The debate about
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how to do so must be strengthened by research into different models and ways of
organising care.  As shown in Chapters 4 and 5, although some models of
‘shared’ diabetes care are based on strict protocols, this is not an absolute pre-
requisite.  Rather, models of shared care can be organised so that they are tailored
to the patient’s and doctor’s individual needs and preferences.  Shared care can
also take into account the presence of specific complications or co-morbidities as
well as the level of training and commitment of the general practitioner. With a
flexible organisation structure, together with close co-operation and open
communication between general practice and specialist care, models such as
shared care can offer an efficient way in which to manage the increasing number
of patients with chronic disease while promoting improved standards of care.
However, there is still a potential for patients to receive either haphazard
duplication of care or neglected care. At least in Australia, many patients are able
to seek care from multiple doctors or regularly change the doctor they see.  Under
the current health system it is the role of the general practitioner to mediate the
movement of patients from primary to secondary care.  Thus, the absence of
continuity of care may lead to a group of patients missing out on the level of care
that they need.  The results of the study reported in Chapter 6 of this thesis
showed that those patients with complications relating to diabetes, mainly
macrovascular disease, who require specialist review, are more likely to seek
continuous care from a single general practitioner.  This would suggest that both
patients and general practitioners recognise the importance of establish a long
term relationship once diabetes management becomes more complex.
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The current challenge is to continue to improve the standard of care patients with
diabetes in Australia receive, taking into consideration available resources.  To
meet this goal the ongoing collection of relevant information to monitor future
trends in standards of care and diabetes service provision is of paramount
importance.  As shown in earlier Chapters, Australia’s universal health insurance
system, known as Medicare, offers a sustainable and reliable system that may play
a vital role in this regard.  Medicare occasions of service data have already
provided unique information on both standards of care and health service
utilisation for people with diabetes living in NSW.  Its ability to provide an almost
complete snap shot of the total picture means it has considerable potential in
regard to ongoing monitoring of both diabetes and other chronic disease.
Moreover, with minor modifications to item code numbers, extensive
epidemiological and public health data could be collected at virtually no cost.
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Appendix 1
The letters and questionnaires sent to the General managers and Directors of
Pathology of all NSW public hospitals to estimate the correction factor for State
funded services not captured by Medicare occasions of service data.
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                                                                          The Diabetes Centre
                                   Royal Prince Alfred Hospital
                                                                                  Level 10, Queen Mary Building
                                                                                          Grose St
Camperdown 2050
                                                                                                                                      Australia
DK Yue,  Director and Professor in Medicine                  Tel: 61 2 95153737          Fax: 61 2 9515 3750
«Date»
General Manager
«Hospital»
«Address1»
«City»  «State»  «PostalCode»
Dear Sir/Madam,
We are currently constructing a profile of diabetes care for people living within
NSW using Medicare occasions of service data.  Unfortunately, this data does not
account for people receiving care entirely through hospital based services.  While
we suspect the number of people retained under the traditional hospital model is
likely to be small, assessment of the extent to which diabetes care remains
hospital based would allow for ‘correction’ of the Medicare data.  We are
therefore writing to seek your help with this process.  We would appreciate you
passing this letter to the most appropriate person within your organisation and
asking them to complete the short questionnaire enclosed.  An envelope is also
enclosed so that the completed questionnaire can be returned to us at your earliest
convenience.
Any information you give us will be treated as strictly confidential.  If you would
like any further information regarding our study please do not hesitate to contact
us on 9515 3737.
Thank you for your help.
Yours sincerely,
Professor Dennis Yue Ms Jane Overland
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Return address:
Jane Overland
Diabetes Centre
Level 10, Queen Mary Building
Grose St
Camperdown  2050
Thank you for your help.  Please complete the following question(s) and return
this page in the envelope provided.
1. Does «Hopsital» have a diabetes clinic:
[    ] yes  (please go to question 2)
[    ] no
2. If yes, can you please provide an estimate of the number of individual
patients (not services) seen at the diabetes clinic last year:
 ________________________
Thank you
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                                                                          The Diabetes Centre
                                   Royal Prince Alfred Hospital
                                                                                  Level 10, Queen Mary Building
                                                                                          Grose St
Camperdown 2050
                                                                                                                                      Australia
    DK Yue,  Director and Professor in Medicine                  Tel: 61 2 95153737          Fax: 61 2 9515 3750
«Date»
Director of Pathology Services
«Hospital»
«Address1»
«City»  «State»  «PostalCode»
Dear Doctor,
We are currently constructing a profile of diabetes care for people living within
NSW using Medicare occasions of service data.  Unfortunately, this data does not
account for services provided by hospital based services.  Assessment of the
extent to which diabetes related pathology is performed through hospital based
laboratories would allow for ‘correction’ of the Medicare data.  We are therefore
writing to seek your help with this process.  This will involve you completing the
short questionnaire enclosed and returning it in the envelope provided.
Any information you give us will be treated as strictly confidential.  If you would
like any further information regarding our study please do not hesitate to contact
us on 9515 3737.
Thank you for your help.
Yours sincerely,
Professor Dennis Yue Ms Jane Overland
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Return address:
Jane Overland
Diabetes Centre
Level 10, Queen Mary Building
Grose St
Camperdown  2050
Thank you for your help.  Please complete the following question(s) and return
this page in the envelope provided.
1. Does «Hospital» have a pathology laboratory:
[    ] yes  (please go to question 2)
[    ] no
2. Does your laboratory perform HbA1c assays:
[    ] yes  (please go to question 3)
[    ] no
3.  a)  If yes, can you please provide an estimate of the number of HbA1c assays
                              your laboratory performed last year:
      ________________________
b) To assist us calculate the correction factor for the Medicare data can you
please indicate what  proportion of these assays are funded by the Federal
Government through Medicare rather than by the NSW health budget (this
information will be treated as strictly confidential):
         ________________________ % Federally funded (Medicare)
           ________________________ % hospital (State) funded
Thank you
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Appendix 2
The letters and questionnaires sent to doctors and patients for those shared care
patients who had not returned for specialist review.  The questionnaires to the
doctors were ‘individualised’ to only include questions regarding treatment areas
where a recommendation had been given.
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The Diabetes Centre
                                   Royal Prince Alfred Hospital
                                                                               Level 10, Queen Mary Building
                                                                                          Grose St
Camperdown 2050
                                                                                                                                      Australia
DK Yue,  Director and Professor in Medicine                  Tel: 61 2 95153737          Fax: 61 2 9515 3750
«Date»
Dr «Doctor name»
«Address 1»
«Address 2»
Dear Dr «Doctor name»,
As a doctor who has referred patients to our Diabetes Centre, you may be aware
that we do not routinely provide regular follow-up.  While we are happy to see
your patients every year or so, we leave re-referral to your discretion.  Many
doctors and patients have asked us to provide a recall service.  We are currently
looking at the feasibility of offering a system to remind general practitioners of
when their patients were last seen by the Diabetes Centre.  With this in mind, we
are contacting a group of doctors and a group of patients who used our services
between 1993 and 1995.
On review of our records we noted that your patient «Name» last attended an
assessment on «Date 2».  We are interested to know what has happened to this
patient since then.  We would appreciate you completing the questions below and
returning this letter to us in the stamp addressed envelope provided.
To thank you for your time your name will be put in a draw for a mixed
dozen of wine upon receipt of your reply.
Yours sincerely,
Dennis Yue Jane Overland
1. Is this patient still in your care?
[    ] Yes
[    ] No
2. If no, please specify the reason
[    ] The patient has moved
[    ] The patient has died
[    ] Don’t know
[    ] Other...............................................................................(please specify)
Thank you very much for your help
166
                                                                  The Diabetes Centre
                                   Royal Prince Alfred Hospital
                                                                                 Level 10, Queen Mary Building
                                                                                          Grose St
Camperdown 2050
                                                                                                                                      Australia
DK Yue,  Director and Professor in Medicine                  Tel: 61 2 95153737          Fax: 61 2 9515 3750
«Date»
Dr «Doctor name»
«Address 1»
«Address 2»
Dear Dr «Doctor name»,
As a doctor who has referred patients to our Diabetes Centre, you may be aware
that we do not routinely provide regular follow-up.  While we are happy to see
your patients every year or so, we leave re-referral to your discretion.   Many
doctors and patients have asked us to provide a recall service. We are currently
looking at the feasibility of offering a system to remind general practitioners of
when their patients were last seen by the Diabetes Centre.  With this in mind, we
are contacting a group of doctors and a group of patients who used our services
between 1993 and 1995.
On review of our records we noted that your patient «Name» last attended an
assessment on «Date 2».  After the assessment, a report was sent to you with
treatment recommendations regarding blood pressure treatment to implement at
your discretion.  We are interested to know what has happened to this patient
since then. Therefore, we would appreciate you completing the short
questionnaire enclosed and returning it to us in the stamp addressed envelope
provided.  We have enclosed a copy of the original report to help you complete
the questions.   This information will help us establish the appropriateness of a
reminder system.
To thank you for your time your name will be put in a draw for a mixed
dozen of wine upon receipt of your reply.
Thank you very much for your help.
Yours sincerely,
Dennis Yue Jane Overland
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1. Is «Name» still in your care?
[    ] Yes (please answer questions 3)
[    ] No (please answer questions 2 and 3)
2. If no, please specify the reason
[    ] the patient has moved
[    ] the patient has died
[    ] Don’t know
[    ] Other...............................................................................(please specify)
3. Did you implement the recommendation regarding blood pressure treatment?
[    ] Yes
[    ] No   
Comment:
Thank you for your help
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                                                                          The Diabetes Centre
                                   Royal Prince Alfred Hospital
                                                                                 Level 10, Queen Mary Building
                                                                                          Grose St
Camperdown 2050
                                                                                                                                      Australia
DK Yue,  Director and Professor in Medicine                  Tel: 61 2 95153737          Fax: 61 2 9515 3750
«Date»
«Name»
«Address 1»
«Address 2»
Dear «Name»,
We are currently thinking about establishing a system to remind your doctor that
it may be time for your diabetes to be reviewed.  With this in mind, we are
contacting a group of doctors and a group of patients who used our services
between 1993 and 1995.
Our records tell us that we last saw you for a full diabetes check-up on «Date 2».
We are interested to know how you have been since then.  Over the next week,
one of the staff of the Diabetes Centre may contact you to ask you a few
questions.  This should only take a few minutes of your time, so we hope that you
will be able to help us.
If you have any questions regarding this letter please do not hesitate to contact
Jane Overland on 9515 3757 Monday to Wednesday.
Yours sincerely,
Dennis Yue Jane Overland
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Appendix 3
The standardised form used to perform the clinical assessment for the
continuity of care study.
